Glucocorticoid-induced	O
apoptosis	O
of	O
human	B-cell_type
leukemic	I-cell_type
cells	I-cell_type
is	O
caused	O
by	O
the	O
repressive	O
function	O
of	O
the	O
glucocorticoid	B-protein
receptor	I-protein
.	O

Induction	O
of	O
apoptosis	O
in	O
lymphocytes	B-cell_type
,	O
which	O
may	O
account	O
for	O
the	O
therapeutic	O
effects	O
of	O
glucocorticoids	O
in	O
various	O
diseases	O
including	O
leukemia	O
,	O
depends	O
on	O
the	O
glucocorticoid	B-protein
receptor	I-protein
.	O

However	O
,	O
the	O
events	O
leading	O
from	O
the	O
activated	O
receptor	O
to	O
cell	O
lysis	O
are	O
not	O
understood	O
.	O

A	O
prevailing	O
hypothesis	O
postulates	O
induction	O
of	O
so-called	O
'	O
lysis	B-DNA
genes	I-DNA
'	O
by	O
the	O
activated	B-protein
receptor	I-protein
.	O

In	O
this	O
study	O
,	O
we	O
show	O
that	O
an	O
activation-deficient	B-protein
glucocorticoid	I-protein
receptor	I-protein
mutant	I-protein
is	O
as	O
effective	O
as	O
the	O
wild-type	B-protein
receptor	I-protein
in	O
repression	O
of	O
AP-1	B-protein
activity	O
,	O
inhibition	O
of	O
interleukin-2	B-protein
production	O
,	O
inhibition	O
of	O
c-myc	B-DNA
expression	O
and	O
induction	O
of	O
apoptosis	O
.	O

Furthermore	O
,	O
we	O
show	O
that	O
retinoic	O
acid	O
can	O
also	O
induce	O
apoptosis	O
in	O
these	O
cells	O
through	O
the	O
retinoic	B-protein
acid	I-protein
receptor	I-protein
,	O
whose	O
repressive	O
functions	O
but	O
not	O
target	O
site	O
specificity	O
,	O
are	O
similar	O
to	O
those	O
of	O
the	O
glucocorticoid	B-protein
receptor	I-protein
.	O

Therefore	O
,	O
the	O
primary	O
effect	O
of	O
the	O
receptor	O
in	O
glucocorticoid-mediated	O
apoptosis	O
correlates	O
with	O
transcriptional	O
repression	O
rather	O
than	O
activation	O
and	O
could	O
be	O
mediated	O
by	O
interference	O
with	O
other	O
transcription	B-protein
factors	I-protein
required	O
for	O
cell	O
survival	O
.	O

The	NULL
EMBO	NULL
Journal	NULL
vol.14	NULL
no.3	NULL
pp.452-460	NULL
,	NULL
1995	NULL
Glucocorticoid-induced	NULL
apoptosis	NULL
of	NULL
human	NULL
leukemic	NULL
cells	NULL
is	NULL
caused	NULL
by	NULL
the	NULL
repressive	NULL
function	NULL
of	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
Arno	NULL
Helmberg	NULL
'	NULL
,	NULL
Nathalie	NULL
Auphan	NULL
,	NULL
Carme	NULL
Caelles	NULL
and	NULL
Michael	NULL
Karin	NULL
?	NULL

Department	NULL
of	NULL
Pharmacology	NULL
,	NULL
Program	NULL
in	NULL
Biomedical	NULL
Sciences	NULL
,	NULL
Center	NULL
for	NULL
Molecular	NULL
Genetics	NULL
,	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
0636	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
92093-0636	NULL
,	NULL
USA	NULL
'Present	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
Institute	NULL
for	NULL
General	NULL
and	NULL
Experimental	NULL
Pathology	NULL
,	NULL
University	NULL
of	NULL
Innsbruck	NULL
Medical	NULL
School	NULL
,	NULL
Fritz	NULL
Pregl-Str	NULL
.	NULL

3	NULL
,	NULL
A-6020	NULL
Innsbruck	NULL
,	NULL
Austria	NULL
Corresponding	NULL
author	NULL
Communicated	NULL
by	NULL
P.Herrlich	NULL
Induction	NULL
of	NULL
apoptosis	NULL
in	NULL
lymphocytes	NULL
,	NULL
which	NULL
may	NULL
account	NULL
for	NULL
the	NULL
therapeutic	NULL
effects	NULL
of	NULL
glucocorticoids	NULL
in	NULL
various	NULL
diseases	NULL
including	NULL
leukemia	NULL
,	NULL
depends	NULL
on	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
.	NULL

However	NULL
,	NULL
the	NULL
events	NULL
leading	NULL
from	NULL
the	NULL
activated	NULL
receptor	NULL
to	NULL
cell	NULL
lysis	NULL
are	NULL
not	NULL
under-stood	NULL
.	NULL

A	NULL
prevailing	NULL
hypothesis	NULL
postulates	NULL
induction	NULL
of	NULL
so-called	NULL
'lysis	NULL
genes	NULL
'	NULL
by	NULL
the	NULL
activated	NULL
receptor	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
show	NULL
that	NULL
an	NULL
activation-deficient	NULL
glucocorticoid	NULL
receptor	NULL
mutant	NULL
is	NULL
as	NULL
effective	NULL
as	NULL
the	NULL
wild-type	NULL
receptor	NULL
in	NULL
repression	NULL
of	NULL
AP-1	NULL
activity	NULL
,	NULL
inhibition	NULL
of	NULL
interleukin-2	NULL
production	NULL
,	NULL
inhibition	NULL
of	NULL
c-mye	NULL
expression	NULL
and	NULL
induction	NULL
of	NULL
apoptosis	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
show	NULL
that	NULL
retinoic	NULL
acid	NULL
can	NULL
also	NULL
induce	NULL
apoptosis	NULL
in	NULL
these	NULL
cells	NULL
through	NULL
the	NULL
retinoic	NULL
acid	NULL
receptor	NULL
,	NULL
whose	NULL
repressive	NULL
functions	NULL
but	NULL
not	NULL
target	NULL
site	NULL
specificity	NULL
,	NULL
are	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
primary	NULL
effect	NULL
of	NULL
the	NULL
receptor	NULL
in	NULL
glucocorticoid-mediated	NULL
apoptosis	NULL
correlates	NULL
with	NULL
transcriptional	NULL
repression	NULL
rather	NULL
than	NULL
activation	NULL
and	NULL
could	NULL
be	NULL
mediated	NULL
by	NULL
interference	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
required	NULL
for	NULL
cell	NULL
survival	NULL
.	NULL

Key	NULL
words	NULL
:	NULL
apoptosis/glucocorticoid/glucocorticoid	NULL
recep-tor/leukemia	NULL
Introduction	NULL
Glucocorticoids	NULL
have	NULL
wide	NULL
medical	NULL
applications	NULL
for	NULL
their	NULL
immunosuppressive	NULL
,	NULL
anti-inflammatory	NULL
and	NULL
,	NULL
in	NULL
some	NULL
cells	NULL
,	NULL
cytostatic	NULL
effects	NULL
.	NULL

Glucocorticoids	NULL
are	NULL
key	NULL
elements	NULL
in	NULL
the	NULL
therapy	NULL
of	NULL
rheumatoid	NULL
arthritis	NULL
,	NULL
collagen	NULL
diseases	NULL
,	NULL
lymphatic	NULL
leukemias	NULL
and	NULL
lymphomas	NULL
(	NULL
Parillo	NULL
and	NULL
Fauci	NULL
,	NULL
1979	NULL
;	NULL
Haynes	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

Despite	NULL
their	NULL
importance	NULL
,	NULL
use	NULL
of	NULL
glucocorticoids	NULL
in	NULL
these	NULL
conditions	NULL
is	NULL
largely	NULL
empirical	NULL
and	NULL
the	NULL
mechanisms	NULL
mediating	NULL
the	NULL
beneficial	NULL
effects	NULL
are	NULL
poorly	NULL
understood	NULL
(	NULL
Haynes	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

One	NULL
relevant	NULL
mechanism	NULL
may	NULL
be	NULL
the	NULL
induction	NULL
of	NULL
cell	NULL
death	NULL
.	NULL

Glucocorticoids	NULL
kill	NULL
immature	NULL
thymocytes	NULL
by	NULL
activating	NULL
a	NULL
suicide	NULL
process	NULL
referred	NULL
to	NULL
as	NULL
apoptosis	NULL
or	NULL
programmed	NULL
cell	NULL
death	NULL
(	NULL
Wyllie	NULL
,	NULL
1980	NULL
;	NULL
Ucker	NULL
,	NULL
1987	NULL
;	NULL
Cohen	NULL
,	NULL
1989	NULL
)	NULL
.	NULL

Likewise	NULL
,	NULL
several	NULL
leukemic	NULL
cell	NULL
lines	NULL
undergo	NULL
this	NULL
type	NULL
of	NULL
cell	NULL
death	NULL
in	NULL
response	NULL
to	NULL
glucocorticoids	NULL
(	NULL
Baxter	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1971	NULL
;	NULL
Sibley	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1974	NULL
;	NULL
Bourgeois	NULL
and	NULL
Newby	NULL
,	NULL
1977	NULL
;	NULL
Norman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
452	NULL
1977	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
glucocorticoids	NULL
were	NULL
reported	NULL
to	NULL
induce	NULL
apoptosis	NULL
in	NULL
mature	NULL
,	NULL
activated	NULL
,	NULL
peripheral	NULL
T	NULL
lymphocytes	NULL
(	NULL
Galili	NULL
,	NULL
1983	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
induction	NULL
of	NULL
apoptosis	NULL
may	NULL
be	NULL
one	NULL
of	NULL
the	NULL
key	NULL
mechanisms	NULL
mediating	NULL
the	NULL
therapeutic	NULL
effect	NULL
of	NULL
glucocorticoids	NULL
in	NULL
the	NULL
treatment	NULL
of	NULL
leukemias	NULL
,	NULL
lymphomas	NULL
and	NULL
various	NULL
autoimmune	NULL
disorders	NULL
.	NULL

The	NULL
glucocorticoid	NULL
receptor	NULL
(	NULL
GR	NULL
)	NULL
is	NULL
required	NULL
for	NULL
glucocorticoid-induced	NULL
apoptosis	NULL
(	NULL
Baxter	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1971	NULL
;	NULL
Sibley	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1974	NULL
)	NULL
,	NULL
but	NULL
the	NULL
GR	NULL
domains	NULL
necessary	NULL
for	NULL
induction	NULL
of	NULL
apoptosis	NULL
have	NULL
been	NULL
controversial	NULL
(	NULL
Nazareth	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Dicken	NULL
and	NULL
Miesfeld	NULL
,	NULL
1992	NULL
)	NULL
,	NULL
as	NULL
have	NULL
been	NULL
the	NULL
relevant	NULL
events	NULL
following	NULL
GR	NULL
activation	NULL
by	NULL
the	NULL
ligand	NULL
(	NULL
Caron-Leslie	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Dowd	NULL
and	NULL
Miesfeld	NULL
,	NULL
1992	NULL
;	NULL
Shi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Thulasi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
activated	NULL
steroid	NULL
receptors	NULL
to	NULL
stimulate	NULL
gene	NULL
expression	NULL
(	NULL
Yamamoto	NULL
and	NULL
Alberts	NULL
,	NULL
1975	NULL
)	NULL
,	NULL
it	NULL
was	NULL
suggested	NULL
that	NULL
glucocorticoid-dependent	NULL
apoptosis	NULL
is	NULL
mediated	NULL
by	NULL
induction	NULL
of	NULL
so-called	NULL
'lysis	NULL
genes	NULL
'	NULL
(	NULL
Gasson	NULL
and	NULL
Bourgeois	NULL
,	NULL
1983	NULL
)	NULL
.	NULL

However	NULL
,	NULL
despite	NULL
major	NULL
efforts	NULL
,	NULL
such	NULL
glucocorticoid-inducible	NULL
'lysis	NULL
genes	NULL
'	NULL
have	NULL
not	NULL
yet	NULL
been	NULL
identified	NULL
.	NULL

Other	NULL
relevant	NULL
mechanisms	NULL
that	NULL
could	NULL
mediate	NULL
the	NULL
therapeutic	NULL
effects	NULL
of	NULL
glucocorticoids	NULL
are	NULL
inhibition	NULL
of	NULL
cell	NULL
proliferation	NULL
(	NULL
reviewed	NULL
by	NULL
Cupps	NULL
and	NULL
Fauci	NULL
,	NULL
1982	NULL
)	NULL
and	NULL
inhibition	NULL
of	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
production	NULL
by	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
Gillis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1979	NULL
;	NULL
Arya	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1984	NULL
)	NULL
.	NULL

The	NULL
latter	NULL
mechanism	NULL
is	NULL
of	NULL
importance	NULL
for	NULL
the	NULL
immunosuppressive	NULL
effects	NULL
of	NULL
glucocorticoids	NULL
because	NULL
IL-2	NULL
production	NULL
is	NULL
critical	NULL
for	NULL
clonal	NULL
expansion	NULL
of	NULL
T	NULL
cells	NULL
and	NULL
other	NULL
immune	NULL
functions	NULL
(	NULL
Gillis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1979	NULL
;	NULL
Cantrell	NULL
and	NULL
Smith	NULL
,	NULL
1984	NULL
)	NULL
.	NULL

It	NULL
was	NULL
suggested	NULL
that	NULL
the	NULL
inhibition	NULL
of	NULL
cell	NULL
proliferation	NULL
and	NULL
IL-2	NULL
production	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
recently	NULL
discovered	NULL
ability	NULL
of	NULL
activated	NULL
GR	NULL
to	NULL
interfere	NULL
with	NULL
transcriptional	NULL
activation	NULL
by	NULL
other	NULL
transcription	NULL
factors	NULL
,	NULL
especially	NULL
AP-1	NULL
(	NULL
Jonat	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Schiile	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Yang-Yen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

This	NULL
hypothesis	NULL
was	NULL
based	NULL
not	NULL
only	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
activated	NULL
GR	NULL
to	NULL
inhibit	NULL
AP-1	NULL
activity	NULL
,	NULL
but	NULL
also	NULL
on	NULL
the	NULL
known	NULL
involvement	NULL
of	NULL
AP-1	NULL
in	NULL
cell	NULL
proliferation	NULL
(	NULL
Kovary	NULL
and	NULL
Bravo	NULL
,	NULL
1991	NULL
;	NULL
reviewed	NULL
by	NULL
Angel	NULL
and	NULL
Karin	NULL
,	NULL
1991	NULL
)	NULL
and	NULL
IL-2	NULL
induction	NULL
(	NULL
Serfling	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Jain	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
analysis	NULL
of	NULL
the	NULL
cis	NULL
elements	NULL
through	NULL
which	NULL
glucocorticoids	NULL
inhibit	NULL
IL-2	NULL
production	NULL
failed	NULL
to	NULL
identify	NULL
GR	NULL
binding	NULL
sites	NULL
(	NULL
GREs	NULL
)	NULL
and	NULL
implicated	NULL
sites	NULL
recognized	NULL
by	NULL
AP-1	NULL
as	NULL
mediators	NULL
of	NULL
this	NULL
effect	NULL
(	NULL
Vacca	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Northrop	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Such	NULL
findings	NULL
raised	NULL
the	NULL
possibility	NULL
that	NULL
induction	NULL
of	NULL
T	NULL
cell	NULL
apoptosis	NULL
may	NULL
also	NULL
be	NULL
mediated	NULL
by	NULL
interference	NULL
with	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
AP-1	NULL
,	NULL
required	NULL
for	NULL
cell	NULL
survival	NULL
rather	NULL
than	NULL
direct	NULL
induction	NULL
of	NULL
'lysis	NULL
genes	NULL
'	NULL
.	NULL

To	NULL
test	NULL
this	NULL
possibility	NULL
we	NULL
introduced	NULL
into	NULL
a	NULL
GR-deficient	NULL
T	NULL
cell	NULL
leukemia	NULL
cell	NULL
line	NULL
,	NULL
expression	NULL
vectors	NULL
encoding	NULL
either	NULL
a	NULL
wild	NULL
type	NULL
(	NULL
wt	NULL
)	NULL
GR	NULL
or	NULL
a	NULL
mutant	NULL
derivative	NULL
that	NULL
is	NULL
defective	NULL
in	NULL
gene	NULL
activation	NULL
but	NULL
fully	NULL
competent	NULL
in	NULL
interference	NULL
with	NULL
AP-1	NULL
activity	NULL
.	NULL

We	NULL
found	NULL
that	NULL
clones	NULL
expressing	NULL
this	NULL
mutant	NULL
GR	NULL
were	NULL
fully	NULL
sensitive	NULL
to	NULL
glucocorticoids	NULL
,	NULL
both	NULL
in	NULL
respect	NULL
of	NULL
inhibition	NULL
of	NULL
IL-2	NULL
production	NULL
©	NULL
Oxford	NULL
University	NULL
Press	NULL
n	NULL
#	NULL
0	NULL
m	NULL
``	NULL
p	NULL
f	NULL
<	NULL
aA	NULL
x	NULL
A	NULL
/	NULL
f	NULL
*	NULL
G	NULL
o	NULL
s	NULL
C	NULL
(	NULL
«	NULL
]	NULL
Glucocorticoid-induced	NULL
apoptosis	NULL
o	NULL
2	NULL
a	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Transcriptional	NULL
repression	NULL
and	NULL
activation	NULL
by	NULL
GR	NULL
mutants	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Primary	NULL
structure	NULL
of	NULL
the	NULL
Zn-finger	NULL
region	NULL
of	NULL
wt	NULL
GR	NULL
and	NULL
LS7	NULL
(	NULL
Godowski	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
wt	NULL
GR	NULL
and	NULL
the	NULL
N-terminal	NULL
deletion	NULL
mutant	NULL
GR-NDel	NULL
.	NULL

AD	NULL
,	NULL
activation	NULL
domain	NULL
;	NULL
DBD	NULL
,	NULL
DNA	NULL
binding	NULL
domain	NULL
;	NULL
LBD	NULL
,	NULL
ligand	NULL
binding	NULL
domain	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Dex-dependent	NULL
repression	NULL
of	NULL
the	NULL
collagenase	NULL
promoter	NULL
in	NULL
TAg-Jurkat	NULL
cells	NULL
(	NULL
Clipstone	NULL
and	NULL
Crabtree	NULL
1992	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
cotransfected	NULL
with	NULL
-73CoI-LUC	NULL
and	NULL
the	NULL
respective	NULL
GR	NULL
expression	NULL
vectors	NULL
or	NULL
the	NULL
empty	NULL
expression	NULL
vector	NULL
pRC/Bact	NULL
,	NULL
grown	NULL
overnight	NULL
and	NULL
treated	NULL
for	NULL
8	NULL
h	NULL
with	NULL
vehicle	NULL
alone	NULL
or	NULL
TPA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
and	NULL
ionomycin	NULL
(	NULL
4	NULL
uM	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
10~	NULL
M	NULL
dex	NULL
.	NULL

Dex	NULL
was	NULL
added	NULL
1	NULL
h	NULL
previous	NULL
to	NULL
TPA	NULL
and	NULL
ionomycin	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Dex-dependent	NULL
induction	NULL
of	NULL
a	NULL
MMTV-LTR	NULL
containing	NULL
two	NULL
consensus	NULL
GREs	NULL
.	NULL

TAg-Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
MMTV-LUC	NULL
and	NULL
the	NULL
same	NULL
expression	NULL
vectors	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

107	NULL
``	NULL
M	NULL
dex	NULL
or	NULL
vehicle	NULL
alone	NULL
was	NULL
added	NULL
1	NULL
h	NULL
after	NULL
transfection	NULL
and	NULL
cells	NULL
were	NULL
harvested	NULL
after	NULL
14	NULL
h.	NULL
and	NULL
in	NULL
undergoing	NULL
apoptosis	NULL
.	NULL

Another	NULL
GR	NULL
mutant	NULL
with	NULL
a	NULL
deletion	NULL
of	NULL
the	NULL
N-terminal	NULL
activation	NULL
domain	NULL
was	NULL
also	NULL
still	NULL
able	NULL
to	NULL
interfere	NULL
with	NULL
AP-1	NULL
activity	NULL
and	NULL
mediate	NULL
glucocorticoid-dependent	NULL
apoptosis	NULL
.	NULL

Likewise	NULL
,	NULL
stable	NULL
expression	NULL
of	NULL
the	NULL
retinoic	NULL
acid	NULL
receptor	NULL
alpha	NULL
(	NULL
RAR	NULL
)	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
different	NULL
response	NULL
elements	NULL
than	NULL
those	NULL
recognized	NULL
by	NULL
the	NULL
GR	NULL
(	NULL
reviewed	NULL
by	NULL
Glass	NULL
and	NULL
Rosenfeld	NULL
,	NULL
1991	NULL
)	NULL
,	NULL
but	NULL
has	NULL
similar	NULL
AP-1	NULL
interfering	NULL
activity	NULL
(	NULL
Schiile	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Yang-Yen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
conferred	NULL
upon	NULL
Jurkat	NULL
cells	NULL
susceptibility	NULL
to	NULL
all-trans	NULL
retinoic	NULL
acid	NULL
(	NULL
RA	NULL
)	NULL
-induced	NULL
apoptosis	NULL
.	NULL

Results	NULL
To	NULL
stably	NULL
express	NULL
various	NULL
versions	NULL
of	NULL
the	NULL
rat	NULL
GR	NULL
in	NULL
a	NULL
subclone	NULL
of	NULL
the	NULL
human	NULL
T	NULL
cell	NULL
leukemia-derived	NULL
Jurkat	NULL
cell	NULL
line	NULL
,	NULL
which	NULL
does	NULL
not	NULL
express	NULL
a	NULL
functional	NULL
endogenous	NULL
GR	NULL
,	NULL
we	NULL
constructed	NULL
expression	NULL
vectors	NULL
containing	NULL
wt	NULL
or	NULL
mutant	NULL
GRs	NULL
under	NULL
control	NULL
of	NULL
a	NULL
B-actin	NULL
promoter	NULL
.	NULL

Mutant	NULL
LS7	NULL
(	NULL
Godowski	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
contains	NULL
two	NULL
adjacent	NULL
amino	NULL
acid	NULL
substitutions	NULL
in	NULL
the	NULL
second	NULL
half	NULL
of	NULL
the	NULL
second	NULL
zinc	NULL
finger	NULL
,	NULL
replacing	NULL
Pro493	NULL
and	NULL
Alad494	NULL
by	NULL
Arg	NULL
and	NULL
Ser	NULL
,	NULL
respectively	NULL
(	NULL
Figure	NULL
1A	NULL
)	NULL
.	NULL

LS7	NULL
was	NULL
reported	NULL
to	NULL
have	NULL
little	NULL
or	NULL
no	NULL
transactivating	NULL
potential	NULL
,	NULL
while	NULL
retaining	NULL
suppressing	NULL
activity	NULL
on	NULL
the	NULL
bovine	NULL
prolactin	NULL
promoter	NULL
(	NULL
Godowski	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Likewise	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
LS7	NULL
to	NULL
interfere	NULL
with	NULL
AP-1-mediated	NULL
transactivation	NULL
of	NULL
the	NULL
collagenase	NULL
promoter	NULL
was	NULL
comparable	NULL
with	NULL
that	NULL
of	NULL
wt	NULL
GR	NULL
(	NULL
Yang-Yen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Mutant	NULL
NDel	NULL
encodes	NULL
a	NULL
truncated	NULL
receptor	NULL
lacking	NULL
the	NULL
amino	NULL
terminal	NULL
activation	NULL
domain	NULL
(	NULL
Figure	NULL
1B	NULL
)	NULL
.	NULL

Transient	NULL
transfections	NULL
were	NULL
performed	NULL
to	NULL
check	NULL
the	NULL
function	NULL
of	NULL
the	NULL
constructs	NULL
and	NULL
to	NULL
determine	NULL
the	NULL
relative	NULL
ability	NULL
of	NULL
the	NULL
receptor	NULL
mutants	NULL
to	NULL
repress	NULL
AP-1	NULL
activity	NULL
and	NULL
to	NULL
transactivate	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
Figure	NULL
1C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

-73Col-LUC	NULL
,	NULL
containing	NULL
a	NULL
truncated	NULL
collagenase	NULL
promoter	NULL
(	NULL
Deng	NULL
and	NULL
Karin	NULL
,	NULL
1993	NULL
)	NULL
,	NULL
was	NULL
used	NULL
as	NULL
an	NULL
AP-1-dependent	NULL
reporter	NULL
to	NULL
examine	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
various	NULL
GRs	NULL
to	NULL
interfere	NULL
with	NULL
AP-1	NULL
activity	NULL
.	NULL

AP-1	NULL
activity	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
-73Col-LUC	NULL
expression	NULL
,	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
non-activated	NULL
Jurkat	NULL
cells	NULL
,	NULL
but	NULL
was	NULL
strongly	NULL
induced	NULL
upon	NULL
cell	NULL
activation	NULL
with	NULL
TPA	NULL
and	NULL
the	NULL
Ca*+*-ionophore	NULL
ionomycin	NULL
.	NULL

All	NULL
GR	NULL
types	NULL
,	NULL
but	NULL
not	NULL
the	NULL
empty	NULL
expression	NULL
vector	NULL
,	NULL
markedly	NULL
suppressed	NULL
this	NULL
induction	NULL
in	NULL
response	NULL
to	NULL
the	NULL
synthetic	NULL
glucocorticoid	NULL
dexamethasone	NULL
(	NULL
dex	NULL
)	NULL
(	NULL
Figure	NULL
1C	NULL
)	NULL
.	NULL

No	NULL
considerable	NULL
differences	NULL
in	NULL
their	NULL
AP-1	NULL
interfering	NULL
activity	NULL
were	NULL
observed	NULL
.	NULL

GRE-mediated	NULL
transactivation	NULL
was	NULL
determined	NULL
by	NULL
a	NULL
MMTV-LUC	NULL
reporter	NULL
containing	NULL
two	NULL
consensus	NULL
GREs	NULL
(	NULL
Drouin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
(	NULL
Figure	NULL
1D	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
previous	NULL
453	NULL
A.Helmberg	NULL
et	NULL
al	NULL
.	NULL

Table	NULL
I.	NULL
Inhibition	NULL
of	NULL
cell	NULL
proliferation	NULL
by	NULL
dex	NULL
dex	NULL
(	NULL
M	NULL
)	NULL
%	NULL
Thymidine	NULL
incorporation	NULL
GRC	NULL
Jurkat	NULL
|	NULL
wt	NULL
LS7	NULL
N-Del	NULL
Di-1	NULL
All-1	NULL
C3-2	NULL
F6-1	NULL
A5-1	NULL
B12-1	NULL
F1Q0-1	NULL
#	NULL
10	NULL
#	NULL
5	NULL
U	NULL
100.0	NULL
+	NULL
9.2	NULL
100.0	NULL
+	NULL
2.0	NULL
100.0	NULL
+	NULL
05.0	NULL
100.0	NULL
+	NULL
08.7	NULL
100.0	NULL
+	NULL
4.2	NULL
100.0	NULL
+	NULL
3.3	NULL
100.0	NULL
+	NULL
5.0	NULL
100.0	NULL
+	NULL
4.2	NULL
100.0	NULL
+	NULL
08.2	NULL
100.0	NULL
+	NULL
3.0	NULL
5x107~	NULL
!	NULL

°	NULL
104.1	NULL
+	NULL
4.1	NULL
95.0	NULL
+	NULL
5.0	NULL
93.3	NULL
*	NULL
15.2	NULL
90.4	NULL
+	NULL
10.5	NULL
61.0	NULL
£	NULL
6.2	NULL
88.8	NULL
£	NULL
4.0	NULL
82.9	NULL
£	NULL
4.7	NULL
1018	NULL
+	NULL
84	NULL
71.9	NULL
£	NULL
144	NULL
85.8	NULL
*	NULL
3.3	NULL
1x107°	NULL
104.5	NULL
+	NULL
4.9	NULL
81.0	NULL
+	NULL
2.9	NULL
68.1	NULL
+	NULL
02.3	NULL
66.8	NULL
+	NULL
04.9	NULL
23.7	NULL
+	NULL
0.2	NULL
90.6	NULL
*	NULL
1.6	NULL
60.0	NULL
+	NULL
4.1	NULL
89.9	NULL
+	NULL
3.0	NULL
41.9	NULL
+	NULL
03.4	NULL
73.9	NULL
*	NULL
1.9	NULL
2x	NULL
10~°	NULL
101.9	NULL
*	NULL
2.3	NULL
50.8	NULL
#	NULL
1.6	NULL
_	NULL
27.8	NULL
*+	NULL
00.3	NULL
19.0	NULL
+	NULL
00.7	NULL
3.4	NULL
#	NULL
0.2	NULL
70.1	NULL
*	NULL
5.1	NULL
32.6	NULL
*	NULL
1.2	NULL
50.4	NULL
*	NULL
3.0	NULL
17.0	NULL
+	NULL
01.0	NULL
61.2	NULL
+	NULL
3.1	NULL
3.3	NULL
%	NULL
10~°	NULL
105.1	NULL
+	NULL
0.7	NULL
31.5	NULL
*	NULL
04	NULL
5.3	NULL
+	NULL
00.1	NULL
5.9	NULL
+	NULL
00.3	NULL
14	NULL
+	NULL
0.0	NULL
55.6	NULL
*	NULL
2.3	NULL
19.8	NULL
*	NULL
0.7	NULL
31.6	NULL
+	NULL
28	NULL
7.7	NULL
%	NULL
00.2	NULL
47.5	NULL
#	NULL
2.1	NULL
5x10~°	NULL
99.1	NULL
+	NULL
2.9	NULL
15.0	NULL
£	NULL
0.2	NULL
-	NULL
1.3	NULL
*	NULL
00.1	NULL
2.0	NULL
+	NULL
00.1	NULL
1.1	NULL
+	NULL
0.0	NULL
29.6	NULL
£	NULL
1.7	NULL
11.5	NULL
*	NULL
0.6	NULL
15.1	NULL
+	NULL
0.8	NULL
4.9	NULL
+	NULL
00.2	NULL
37.9	NULL
*	NULL
1.0	NULL
1x10~8	NULL
82.5	NULL
*	NULL
3.7	NULL
5.2	NULL
+	NULL
0.3	NULL
0.7	NULL
+	NULL
00.0	NULL
1.3	NULL
+	NULL
00.4	NULL
_	NULL
1.2	NULL
+	NULL
0.3	NULL
12.3	NULL
*	NULL
0.3	NULL
7.0	NULL
*	NULL
0.5	NULL
6.8	NULL
+	NULL
0.5	NULL
3.0	NULL
+	NULL
00.1	NULL
224	NULL
*	NULL
0.8	NULL
1x107	NULL
``	NULL
86.2	NULL
+	NULL
2.1	NULL
1.6	NULL
*+	NULL
0.2	NULL
0.5	NULL
+	NULL
00.1	NULL
0.9	NULL
+	NULL
00.3	NULL
1.1	NULL
+	NULL
0.4	NULL
3.5	NULL
*	NULL
0.3	NULL
3.0	NULL
*	NULL
2.2	NULL
1.7	NULL
*+	NULL
0.2	NULL
1.5	NULL
+	NULL
00.1	NULL
9.1	NULL
+	NULL
0.9	NULL
Rec./cell	NULL
-	NULL
43	NULL
000	NULL
72	NULL
000	NULL
78	NULL
000	NULL
78	NULL
000	NULL
32	NULL
000	NULL
66	NULL
000	NULL
29	NULL
000	NULL
ND	NULL
ND	NULL
Parental	NULL
GR~	NULL
Jurkat	NULL
cells	NULL
and	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
GR-wt	NULL
,	NULL
GR-LS7	NULL
or	NULL
GR-NDel	NULL
were	NULL
seeded	NULL
in	NULL
microtiter	NULL
plates	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
indicated	NULL
concentrations	NULL
of	NULL
dex	NULL
and	NULL
grown	NULL
for	NULL
42	NULL
h	NULL
,	NULL
followed	NULL
by	NULL
8	NULL
h	NULL
of	NULL
incorporation	NULL
.	NULL

Numbers	NULL
are	NULL
percent	NULL
thymidine	NULL
incorporation	NULL
*	NULL
1	NULL
standard	NULL
deviation	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
vehicle	NULL
control	NULL
for	NULL
each	NULL
clone	NULL
.	NULL

For	NULL
wt	NULL
and	NULL
LS7	NULL
clones	NULL
,	NULL
receptor	NULL
numbers	NULL
per	NULL
cell	NULL
as	NULL
determined	NULL
by	NULL
Scatchard	NULL
analysis	NULL
are	NULL
listed	NULL
below	NULL
the	NULL
thymidine	NULL
incorporation	NULL
data	NULL
.	NULL

ND	NULL
,	NULL
not	NULL
determined	NULL
.	NULL

results	NULL
in	NULL
CV-1	NULL
cells	NULL
,	NULL
LS7	NULL
exhibited	NULL
minimal	NULL
transactivating	NULL
potential	NULL
,	NULL
while	NULL
GR-NDel	NULL
demonstrated	NULL
intermediate	NULL
dex-dependent	NULL
transactivation	NULL
amounting	NULL
to	NULL
40	NULL
%	NULL
of	NULL
GR-wt	NULL
,	NULL
mirroring	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
similarly	NULL
structured	NULL
mutant	NULL
A77-262	NULL
in	NULL
CV-1	NULL
cells	NULL
(	NULL
Yang-Yen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Using	NULL
these	NULL
plasmids	NULL
,	NULL
several	NULL
stably	NULL
transfected	NULL
cell	NULL
clones	NULL
were	NULL
isolated	NULL
that	NULL
constitutively	NULL
expressed	NULL
either	NULL
wt	NULL
GR	NULL
or	NULL
one	NULL
of	NULL
the	NULL
mutants	NULL
.	NULL

GRE-mediated	NULL
transactivation	NULL
in	NULL
GR-wt	NULL
,	NULL
GR-LS7	NULL
clones	NULL
and	NULL
in	NULL
parental	NULL
Jurkat	NULL
cells	NULL
is	NULL
shown	NULL
in	NULL
Figure	NULL
2	NULL
.	NULL

The	NULL
difference	NULL
in	NULL
activation	NULL
of	NULL
transiently	NULL
transfected	NULL
MMTV-LUC	NULL
between	NULL
GR-wt	NULL
and	NULL
GR-LS7	NULL
clones	NULL
was	NULL
found	NULL
to	NULL
be	NULL
~10-	NULL
to	NULL
20-fold	NULL
at	NULL
maximum	NULL
receptor	NULL
occupancy	NULL
,	NULL
at	NULL
and	NULL
above	NULL
10~8	NULL
M	NULL
dex	NULL
.	NULL

Dex	NULL
concentrations	NULL
considerably	NULL
below	NULL
the	NULL
one	NULL
commonly	NULL
used	NULL
(	NULL
10~°	NULL
M	NULL
)	NULL
efficiently	NULL
inhibited	NULL
proliferation	NULL
of	NULL
clones	NULL
expressing	NULL
either	NULL
GR	NULL
type	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
cell	NULL
proliferation	NULL
,	NULL
measured	NULL
by	NULL
thymidine	NULL
incorporation	NULL
,	NULL
was	NULL
virtually	NULL
identical	NULL
for	NULL
GR-wt	NULL
,	NULL
GR-LS7	NULL
and	NULL
GR-NDel-expressing	NULL
clones	NULL
.	NULL

Dex	NULL
concentrations	NULL
of	NULL
10~°	NULL
%	NULL
M	NULL
or	NULL
higher	NULL
,	NULL
completely	NULL
abrogated	NULL
proliferation	NULL
,	NULL
whereas	NULL
the	NULL
responses	NULL
were	NULL
more	NULL
gradual	NULL
in	NULL
the	NULL
nanomolar	NULL
range	NULL
for	NULL
each	NULL
receptor	NULL
type	NULL
.	NULL

Although	NULL
clonal	NULL
variability	NULL
was	NULL
observed	NULL
,	NULL
no	NULL
consistent	NULL
differences	NULL
were	NULL
detected	NULL
between	NULL
clones	NULL
expressing	NULL
GR-wt	NULL
,	NULL
GR-LS7	NULL
or	NULL
NDel	NULL
.	NULL

The	NULL
parental	NULL
cells	NULL
were	NULL
insensitive	NULL
to	NULL
dex	NULL
.	NULL

Scatchard	NULL
analyses	NULL
were	NULL
performed	NULL
for	NULL
GR-wt	NULL
,	NULL
GR-LS7	NULL
and	NULL
the	NULL
parental	NULL
cells	NULL
to	NULL
determine	NULL
receptor	NULL
numbers	NULL
of	NULL
individual	NULL
clones	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
,	NULL
using	NULL
binding	NULL
to	NULL
whole	NULL
cells	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Helmberg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

The	NULL
observed	NULL
receptor	NULL
numbers	NULL
ranged	NULL
between	NULL
30	NULL
000	NULL
and	NULL
80	NULL
000	NULL
per	NULL
cell	NULL
and	NULL
were	NULL
somewhat	NULL
higher	NULL
than	NULL
the	NULL
14	NULL
000	NULL
endogenous	NULL
receptors	NULL
found	NULL
in	NULL
the	NULL
lymphoblastic	NULL
leukemic	NULL
CEM-C7	NULL
cell	NULL
line	NULL
(	NULL
Harbour	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
but	NULL
lower	NULL
than	NULL
the	NULL
125	NULL
000	NULL
endogenous	NULL
receptors	NULL
in	NULL
the	NULL
P388D1	NULL
cell	NULL
line	NULL
(	NULL
Helmberg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Clones	NULL
with	NULL
higher	NULL
receptor	NULL
numbers	NULL
tended	NULL
to	NULL
be	NULL
more	NULL
sensitive	NULL
to	NULL
dex	NULL
.	NULL

Receptors	NULL
from	NULL
all	NULL
clones	NULL
bound	NULL
dex	NULL
with	NULL
virtually	NULL
the	NULL
same	NULL
affinity	NULL
(	NULL
K	NULL
,	NULL
=	NULL
3-5	NULL
nM	NULL
)	NULL
.	NULL

No	NULL
specific	NULL
binding	NULL
of	NULL
dex	NULL
was	NULL
detected	NULL
in	NULL
parental	NULL
cells	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
by	NULL
measuring	NULL
the	NULL
effect	NULL
of	NULL
dex	NULL
on	NULL
cell	NULL
viability	NULL
using	NULL
trypan	NULL
blue	NULL
exclusion	NULL
(	NULL
Figure	NULL
3A	NULL
)	NULL
.	NULL

These	NULL
assays	NULL
revealed	NULL
massive	NULL
cell	NULL
death	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
dex	NULL
beginning	NULL
after	NULL
~24	NULL
h.	NULL
DNA	NULL
fragmentation	NULL
454	NULL
1501	NULL
O	NULL
2	NULL
-J	NULL
2	NULL
1001	NULL
3	NULL
S	NULL
5	NULL
C	NULL
5	NULL
$	NULL
-	NULL
s01	NULL
€	NULL
C	NULL
1	NULL
``	NULL
|	NULL
|	NULL
0	NULL
aan	NULL
1	NULL
1	NULL
I	NULL
llI|	NULL
llll	NULL
IIII	NULL
ll	NULL
``	NULL
Alli	NULL
3	NULL
C	NULL
-	NULL
v	NULL
+-®0	NULL
to	NULL
to	NULL
Ao	NULL
$	NULL
%	NULL
of	NULL
on	NULL
a	NULL
§	NULL
g	NULL
a	NULL
&	NULL
8	NULL
g	NULL
%	NULL
a	NULL
E	NULL
GR-wt	NULL
GRLS7	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

GR-mediated	NULL
transactivation	NULL
in	NULL
parental	NULL
and	NULL
stably	NULL
transfected	NULL
Jurkat	NULL
cells	NULL
.	NULL

Parental	NULL
GR~	NULL
Jurkat	NULL
cells	NULL
,	NULL
three	NULL
clones	NULL
expressing	NULL
GR-wt	NULL
and	NULL
five	NULL
clones	NULL
expressing	NULL
GR-LS7	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
with	NULL
MMTV-LUC	NULL
reporter	NULL
,	NULL
Cells	NULL
were	NULL
divided	NULL
into	NULL
five	NULL
batches	NULL
and	NULL
treated	NULL
for	NULL
16	NULL
h	NULL
with	NULL
either	NULL
vehicle	NULL
(	NULL
ethanol	NULL
)	NULL
alone	NULL
or	NULL
3X	NULL
10-	NULL
'	NULL
%	NULL
,	NULL
1x10~°	NULL
,	NULL
3x	NULL
107°	NULL
and	NULL
1078	NULL
M	NULL
dex	NULL
.	NULL

For	NULL
each	NULL
clone	NULL
,	NULL
the	NULL
four	NULL
bars	NULL
indicate	NULL
luciferase	NULL
activity	NULL
in	NULL
dex	NULL
treated	NULL
wells	NULL
divided	NULL
by	NULL
luciferase	NULL
activity	NULL
in	NULL
the	NULL
vehicle	NULL
control	NULL
.	NULL

by	NULL
internucleosomal	NULL
cleavage	NULL
,	NULL
a	NULL
hallmark	NULL
of	NULL
apoptosis	NULL
(	NULL
Wyllie	NULL
,	NULL
1980	NULL
)	NULL
,	NULL
was	NULL
detected	NULL
after	NULL
a	NULL
40	NULL
h	NULL
incubation	NULL
with	NULL
dex	NULL
in	NULL
GR-wt	NULL
,	NULL
GR-LS7	NULL
and	NULL
GR-NDel-expressing	NULL
clones	NULL
,	NULL
but	NULL
not	NULL
in	NULL
the	NULL
parental	NULL
cells	NULL
(	NULL
Figure	NULL
3B	NULL
)	NULL
.	NULL

Attempts	NULL
to	NULL
block	NULL
this	NULL
effect	NULL
of	NULL
dex	NULL
with	NULL
cycloheximide	NULL
or	NULL
actinomycin	NULL
D	NULL
(	NULL
Cohen	NULL
and	NULL
Duke	NULL
,	NULL
1984	NULL
)	NULL
,	NULL
revealed	NULL
that	NULL
either	NULL
agent	NULL
induces	NULL
DNA	NULL
fragmentation	NULL
by	NULL
itself	NULL
,	NULL
as	NULL
shown	NULL
for	NULL
other	NULL
lymphoid	NULL
cells	NULL
(	NULL
Martin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Bazar	NULL
and	NULL
Deeg	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
apoptosis	NULL
was	NULL
also	NULL
confirmed	NULL
by	NULL
morphological	NULL
criteria	NULL
,	NULL
such	NULL
as	NULL
cell	NULL
shrinkage	NULL
and	NULL
breakdown	NULL
of	NULL
the	NULL
cell	NULL
into	NULL
apoptotic	NULL
bodies	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Most	NULL
importantly	NULL
,	NULL
the	NULL
inhibition	NULL
of	NULL
cell	NULL
proliferation	NULL
and	NULL
eventually	NULL
cell	NULL
killing	NULL
did	NULL
not	NULL
correlate	NULL
with	NULL
transcriptional	NULL
activation	NULL
by	NULL
the	NULL
GR	NULL
.	NULL

For	NULL
example	NULL
,	NULL
GR-wt	NULL
clone	NULL
D1-1	NULL
(	NULL
43	NULL
000	NULL
receptors/cell	NULL
)	NULL
responds	NULL
to	NULL
10~°	NULL
M	NULL
dex	NULL
with	NULL
a	NULL
J	NULL
300	NULL
parental	NULL
200	NULL
1	NULL
100	NULL
1	NULL
viable	NULL
cells	NULL
(	NULL
x10	NULL
000	NULL
)	NULL
+	NULL
hours	NULL
10	NULL
20	NULL
30	NULL
40	NULL
50	NULL
o	NULL
300	NULL
GBR-wt	NULL
200	NULL
1	NULL
100	NULL
1	NULL
viable	NULL
cells	NULL
(	NULL
x10	NULL
000	NULL
)	NULL
o	NULL
_s	NULL
o	NULL
ho	NULL
o	NULL
t	NULL
o	NULL
$	NULL
&	NULL
0	NULL
50	NULL
300	NULL
GR-LS7	NULL
200	NULL
1	NULL
viable	NULL
cells	NULL
(	NULL
x10	NULL
000	NULL
)	NULL
0	NULL
u	NULL
u	NULL
r	NULL
T	NULL
30	NULL
40	NULL
50	NULL
hours	NULL
le	NULL
]	NULL
we	NULL
o	NULL
ho	NULL
o	NULL
hours	NULL
Glucocorticoid-induced	NULL
apoptosis	NULL
B	NULL
parental	NULL
_	NULL
GR-wt	NULL
-	NULL
GR-LS7	NULL
GR-NDel	NULL
ssi	NULL
FEH	NULL
7	NULL
N	NULL
T	NULL
origin	NULL
»	NULL
La	NULL
2000	NULL
i	NULL
>	NULL
«	NULL
=	NULL
»	NULL
>	NULL
cem	NULL
»	NULL
1000	NULL
i	NULL
>	NULL
«	NULL
«	NULL
»	NULL
»	NULL
500	NULL
b	NULL
”	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Dex-mediated	NULL
apoptosis	NULL
of	NULL
GR-expressing	NULL
Jurkat	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Cell	NULL
kinetics	NULL
assayed	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
of	NULL
parental	NULL
cells	NULL
,	NULL
GR-wt	NULL
clone	NULL
D1-1	NULL
and	NULL
GR-LS7	NULL
clone	NULL
F6-1	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
vehicle	NULL
alone	NULL
(	NULL
0	NULL
)	NULL
,	NULL
10~'°	NULL
M	NULL
dex	NULL
(	NULL
¥	NULL
)	NULL
,	NULL
10~°	NULL
M	NULL
dex	NULL
(	NULL
MW	NULL
)	NULL
,	NULL
and	NULL
1078	NULL
M	NULL
dex	NULL
(	NULL
@	NULL
)	NULL
.	NULL

Non-stained	NULL
cells	NULL
were	NULL
regarded	NULL
as	NULL
viable	NULL
cells	NULL
,	NULL
even	NULL
if	NULL
the	NULL
beginning	NULL
of	NULL
cell	NULL
fragmentation	NULL
was	NULL
already	NULL
clearly	NULL
visible	NULL
.	NULL

(	NULL
B	NULL
)	NULL
DNA	NULL
fragmentation	NULL
associated	NULL
with	NULL
glucocorticoid-induced	NULL
apoptosis	NULL
.	NULL

Parental	NULL
,	NULL
GR-wt	NULL
,	NULL
GR-LS7	NULL
and	NULL
GR-NDel	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
10~8	NULL
M	NULL
dex	NULL
.	NULL

After	NULL
40	NULL
h	NULL
,	NULL
DNA	NULL
was	NULL
extracted	NULL
,	NULL
end-labeled	NULL
with	NULL
[	NULL
&	NULL
-*P	NULL
]	NULL
ddATP	NULL
,	NULL
electrophoresed	NULL
through	NULL
a	NULL
2	NULL
%	NULL
agarose	NULL
gel	NULL
and	NULL
autoradiographed	NULL
.	NULL

40-fold	NULL
activation	NULL
of	NULL
MMTV-LUC	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
,	NULL
but	NULL
with	NULL
litle	NULL
inhibition	NULL
of	NULL
cell	NULL
proliferation	NULL
(	NULL
81	NULL
%	NULL
thymidine	NULL
incorporation	NULL
)	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
and	NULL
loss	NULL
of	NULL
viable	NULL
cell	NULL
count	NULL
(	NULL
Figure	NULL
3A	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
GR-LS7	NULL
clone	NULL
F6-1	NULL
(	NULL
78	NULL
000	NULL
receptors/cell	NULL
)	NULL
demonstrates	NULL
only	NULL
3-fold	NULL
activation	NULL
of	NULL
MMTV-LUC	NULL
at	NULL
10-°	NULL
M	NULL
dex	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
,	NULL
but	NULL
considerable	NULL
inhibition	NULL
of	NULL
thymidine	NULL
incorporation	NULL
(	NULL
23	NULL
%	NULL
incorporation	NULL
)	NULL
and	NULL
loss	NULL
of	NULL
viable	NULL
cell	NULL
count	NULL
(	NULL
Figure	NULL
3A	NULL
)	NULL
.	NULL

To	NULL
compare	NULL
the	NULL
activating	NULL
and	NULL
suppressive	NULL
activities	NULL
of	NULL
the	NULL
wt	NULL
GR	NULL
and	NULL
the	NULL
LS7	NULL
mutant	NULL
on	NULL
transcription	NULL
of	NULL
endogenous	NULL
genes	NULL
in	NULL
our	NULL
stably	NULL
transfected	NULL
clones	NULL
,	NULL
we	NULL
chose	NULL
glutamine	NULL
synthase	NULL
and	NULL
IL-2	NULL
expression	NULL
as	NULL
indica-tors	NULL
.	NULL

The	NULL
glutamine	NULL
synthase	NULL
promoter	NULL
contains	NULL
a	NULL
GRE	NULL
and	NULL
is	NULL
glucocorticoid	NULL
inducible	NULL
(	NULL
Pu	NULL
and	NULL
Young	NULL
,	NULL
1989	NULL
)	NULL
.	NULL

IL-2	NULL
induction	NULL
is	NULL
inhibited	NULL
by	NULL
glucocorticoids	NULL
(	NULL
Gillis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1979	NULL
;	NULL
Arya	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1984	NULL
)	NULL
,	NULL
and	NULL
the	NULL
cis	NULL
elements	NULL
mediating	NULL
this	NULL
inhibition	NULL
were	NULL
identified	NULL
(	NULL
Vacca	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Northrop	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

As	NULL
in	NULL
the	NULL
case	NULL
of	NULL
the	NULL
collagenase	NULL
promoter	NULL
,	NULL
455	NULL
A.Helmberg	NULL
ot	NULL
al	NULL
.	NULL

A	NULL
parental	NULL
GR-wt	NULL
GR-LS7	NULL
Dexamethasone	NULL
-o	NULL
-	NULL
+	NULL
#	NULL
_	NULL
o=	NULL
4	NULL
%	NULL
so	NULL
~	NULL
TPA/lonomycin	NULL
=	NULL
+o	NULL
+	NULL
80g	NULL
oy	NULL
+	NULL
c-	NULL
Tubulin	NULL
c-jun	NULL
c-fos	NULL
B	NULL
parental	NULL
GR-wt	NULL
GR-LS7	NULL
D1-1	NULL
A11-1	NULL
F6-1	NULL
B12-1	NULL
-	NULL
C3-2	NULL
dex	NULL
_	NULL
[	NULL
-	NULL
+	NULL
]	NULL
[	NULL
-	NULL
+1	NULL
]	NULL
1-	NULL
+~1	NULL
[	NULL
-	NULL
+~1	NULL
[	NULL
-	NULL
+1	NULL
[	NULL
-	NULL
+I	NULL
GS	NULL
a	NULL
saga-as	NULL
”	NULL
Aﬂmmm	NULL
dum	NULL
myc	NULL
souk	NULL
-	NULL
wii	NULL
doa	NULL
dak	NULL
tub	NULL
-	NULL
dhol	NULL
mal	NULL
tmul	NULL
cose	NULL
Cut	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Effects	NULL
of	NULL
dex	NULL
on	NULL
gene	NULL
expression	NULL
in	NULL
parental	NULL
,	NULL
GR-wt	NULL
and	NULL
GR-LS7	NULL
Jurkat	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Cells	NULL
were	NULL
treated	NULL
for	NULL
8	NULL
h	NULL
(	NULL
IL-2	NULL
)	NULL
or	NULL
1	NULL
h	NULL
(	NULL
c-jun	NULL
,	NULL
c-fos	NULL
)	NULL
as	NULL
indicated	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
extracted	NULL
and	NULL
20	NULL
jig	NULL
per	NULL
lane	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
a	NULL
nylon	NULL
membrane	NULL
and	NULL
analyzed	NULL
by	NULL
hybridization	NULL
using	NULL
probes	NULL
specific	NULL
for	NULL
human	NULL
IL-2	NULL
,	NULL
c-jun	NULL
,	NULL
o-tubulin	NULL
and	NULL
murine	NULL
c-fos	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Cells	NULL
were	NULL
grown	NULL
for	NULL
3	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
dex	NULL
(	NULL
107	NULL
%	NULL
M	NULL
)	NULL
,	NULL
and	NULL
RNA	NULL
was	NULL
extracted	NULL
and	NULL
analyzed	NULL
with	NULL
probes	NULL
for	NULL
human	NULL
glutamine	NULL
synthase	NULL
(	NULL
Van	NULL
den	NULL
Hoff	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
c-myc	NULL
and	NULL
-tubulin	NULL
.	NULL

Note	NULL
that	NULL
GR-LS7	NULL
clone	NULL
C3-2	NULL
,	NULL
which	NULL
shows	NULL
a	NULL
small	NULL
induction	NULL
of	NULL
glutamine	NULL
synthase	NULL
mRNA	NULL
is	NULL
also	NULL
the	NULL
clone	NULL
with	NULL
the	NULL
highest	NULL
residual	NULL
transcriptional	NULL
activity	NULL
shown	NULL
in	NULL
Figure	NULL
2	NULL
,	NULL
and	NULL
that	NULL
the	NULL
two	NULL
C3-2	NULL
lanes	NULL
contain	NULL
more	NULL
RNA	NULL
than	NULL
the	NULL
other	NULL
lanes	NULL
.	NULL

they	NULL
do	NULL
not	NULL
bind	NULL
GR	NULL
,	NULL
but	NULL
are	NULL
recognized	NULL
by	NULL
either	NULL
AP-1	NULL
or	NULL
NF-IL-2A	NULL
,	NULL
which	NULL
is	NULL
a	NULL
complex	NULL
between	NULL
AP-1	NULL
and	NULL
Octl	NULL
(	NULL
Northrop	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Ullman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
IL-2	NULL
in	NULL
supernatants	NULL
of	NULL
untreated	NULL
,	NULL
TPA/ionomycin-stimulated	NULL
or	NULL
TPA/ionomycin	NULL
+	NULL
dex-treated	NULL
cells	NULL
was	NULL
quantitated	NULL
by	NULL
a	NULL
bioassay	NULL
(	NULL
Gillis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1978	NULL
)	NULL
.	NULL

Marked	NULL
inhibition	NULL
of	NULL
IL-2	NULL
production	NULL
by	NULL
dex	NULL
was	NULL
observed	NULL
in	NULL
both	NULL
GR-wt	NULL
and	NULL
GR-LS7	NULL
clones	NULL
,	NULL
but	NULL
not	NULL
in	NULL
the	NULL
parental	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
also	NULL
analyzed	NULL
IL-2	NULL
mRNA	NULL
steady	NULL
state	NULL
levels	NULL
after	NULL
8	NULL
h	NULL
of	NULL
stimulation	NULL
to	NULL
avoid	NULL
non-specific	NULL
effects	NULL
due	NULL
to	NULL
cell	NULL
killing	NULL
.	NULL

Induction	NULL
of	NULL
IL-2	NULL
mRNA	NULL
was	NULL
strongly	NULL
suppressed	NULL
by	NULL
dex	NULL
in	NULL
both	NULL
GR-wt	NULL
and	NULL
GR-LS7	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
in	NULL
parental	NULL
cells	NULL
(	NULL
Figure	NULL
4A	NULL
)	NULL
.	NULL

The	NULL
same	NULL
result	NULL
was	NULL
found	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
by	NULL
CD3-crosslinking	NULL
(	NULL
Weiss	NULL
and	NULL
Stobo	NULL
,	NULL
1984	NULL
)	NULL
,	NULL
instead	NULL
of	NULL
TPA/	NULL
ionomycin	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
dex	NULL
did	NULL
not	NULL
inhibit	NULL
induction	NULL
of	NULL
c-jun	NULL
or	NULL
c-fos	NULL
mRNAs	NULL
by	NULL
TPA	NULL
and	NULL
ionomycin	NULL
(	NULL
Figure	NULL
4A	NULL
)	NULL
.	NULL

This	NULL
pattern	NULL
is	NULL
identical	NULL
to	NULL
that	NULL
described	NULL
previously	NULL
for	NULL
HeLa	NULL
cells	NULL
(	NULL
Jonat	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Yang-Yen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
activated	NULL
GR	NULL
interferes	NULL
with	NULL
AP-1	NULL
activity	NULL
,	NULL
interference	NULL
is	NULL
not	NULL
due	NULL
to	NULL
inhibition	NULL
of	NULL
jun	NULL
and	NULL
fos	NULL
gene	NULL
expression	NULL
.	NULL

Recently	NULL
,	NULL
Thulasi	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
reported	NULL
that	NULL
glucocorticoid	NULL
treatment	NULL
of	NULL
a	NULL
leukemic	NULL
cell	NULL
line	NULL
repressed	NULL
c-myc	NULL
expression	NULL
.	NULL

We	NULL
checked	NULL
c-myc	NULL
expression	NULL
in	NULL
our	NULL
system	NULL
and	NULL
found	NULL
that	NULL
as	NULL
early	NULL
456	NULL
as	NULL
90	NULL
min	NULL
after	NULL
dex	NULL
application	NULL
,	NULL
c-myc	NULL
was	NULL
repressed	NULL
in	NULL
all	NULL
of	NULL
the	NULL
GR-wt	NULL
and	NULL
GR-LS7-expressing	NULL
clones	NULL
but	NULL
not	NULL
in	NULL
the	NULL
parental	NULL
GR~	NULL
Jurkat	NULL
cells	NULL
(	NULL
Figure	NULL
4B	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
dex-mediated	NULL
induction	NULL
of	NULL
the	NULL
glutamine	NULL
synthase	NULL
gene	NULL
,	NULL
which	NULL
is	NULL
positively	NULL
regulated	NULL
by	NULL
glucocorticoids	NULL
,	NULL
was	NULL
observed	NULL
only	NULL
in	NULL
wt	NULL
GR-expressing	NULL
clones	NULL
and	NULL
not	NULL
in	NULL
the	NULL
parental	NULL
GR~	NULL
cells	NULL
or	NULL
in	NULL
LS7-expressing	NULL
clones	NULL
.	NULL

As	NULL
a	NULL
more	NULL
comprehensive	NULL
screen	NULL
for	NULL
the	NULL
effects	NULL
of	NULL
GR-wt	NULL
and	NULL
GR-LS7	NULL
on	NULL
expression	NULL
of	NULL
endogenous	NULL
genes	NULL
,	NULL
we	NULL
used	NULL
differential	NULL
mRNA	NULL
display	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
as	NULL
described	NULL
by	NULL
Liang	NULL
and	NULL
Pardee	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

To	NULL
exclude	NULL
secondary	NULL
effects	NULL
on	NULL
gene	NULL
expression	NULL
,	NULL
parental	NULL
GR~	NULL
,	NULL
GR-wt	NULL
and	NULL
GR-LS7	NULL
cells	NULL
were	NULL
grown	NULL
for	NULL
3	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cycloheximide	NULL
,	NULL
with	NULL
and	NULL
without	NULL
10~8	NULL
M	NULL
dex	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
purified	NULL
,	NULL
reverse	NULL
transcribed	NULL
and	NULL
the	NULL
resulting	NULL
cDNAs	NULL
amplified	NULL
and	NULL
separated	NULL
over	NULL
a	NULL
sequencing	NULL
gel	NULL
.	NULL

Whereas	NULL
the	NULL
vast	NULL
majority	NULL
of	NULL
cDNAs	NULL
appeared	NULL
in	NULL
equal	NULL
abundance	NULL
in	NULL
all	NULL
three	NULL
clones	NULL
,	NULL
independently	NULL
of	NULL
hormone	NULL
treatment	NULL
,	NULL
several	NULL
examples	NULL
of	NULL
induced	NULL
and	NULL
repressed	NULL
genes	NULL
were	NULL
detected	NULL
(	NULL
Figure	NULL
5	NULL
)	NULL
.	NULL

The	NULL
dex-induced	NULL
cDNA	NULL
species	NULL
shown	NULL
in	NULL
the	NULL
upper	NULL
panel	NULL
of	NULL
Figure	NULL
5	NULL
was	NULL
reproducibly	NULL
detected	NULL
several	NULL
times	NULL
and	NULL
was	NULL
consistently	NULL
found	NULL
to	NULL
be	NULL
induced	NULL
only	NULL
in	NULL
GR-wt-expressing	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
in	NULL
GR-LS7-expressing	NULL
cells	NULL
or	NULL
in	NULL
parental	NULL
GR~	NULL
cells	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
cDNAs	NULL
whose	NULL
abund-	NULL
par	NULL
wt	NULL
LS7	NULL
1	NULL
[	NULL
--	NULL
A	NULL
dex	NULL
+o	NULL
-	NULL
+	NULL
«	NULL
i	NULL
>	NULL
ca	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Global	NULL
effects	NULL
of	NULL
dex	NULL
on	NULL
gene	NULL
expression	NULL
revealed	NULL
by	NULL
differential	NULL
mRNA	NULL
display	NULL
.	NULL

Parental	NULL
,	NULL
GR-wt	NULL
and	NULL
GR-LS7	NULL
cells	NULL
were	NULL
grown	NULL
for	NULL
3	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cycloheximide	NULL
,	NULL
with	NULL
and	NULL
without	NULL
1078	NULL
M	NULL
dex	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
purified	NULL
and	NULL
reverse	NULL
transcribed	NULL
using	NULL
anchored	NULL
primers	NULL
,	NULL
followed	NULL
by	NULL
sets	NULL
of	NULL
PCRs	NULL
using	NULL
the	NULL
anchored	NULL
primer	NULL
and	NULL
different	NULL
10mers	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
*°S	NULL
]	NULL
dATP	NULL
.	NULL

The	NULL
resulting	NULL
amplified	NULL
cDNAs	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
sequencing	NULL
gel	NULL
and	NULL
and	NULL
autoradiographed	NULL
.	NULL

Due	NULL
to	NULL
the	NULL
ragged	NULL
ends	NULL
of	NULL
PCR	NULL
products	NULL
,	NULL
copies	NULL
from	NULL
the	NULL
same	NULL
cDNA	NULL
can	NULL
differ	NULL
in	NULL
size	NULL
by	NULL
four	NULL
to	NULL
six	NULL
nucleotides	NULL
.	NULL

Shown	NULL
are	NULL
examples	NULL
of	NULL
one	NULL
dex-inducible	NULL
cDNA	NULL
product	NULL
which	NULL
is	NULL
induced	NULL
only	NULL
in	NULL
wt-GR-expressing	NULL
cells	NULL
and	NULL
one	NULL
dex-repressible	NULL
cDNA	NULL
product	NULL
that	NULL
is	NULL
repressed	NULL
in	NULL
both	NULL
wt-GR	NULL
and	NULL
LS7-expressing	NULL
cells	NULL
.	NULL

ance	NULL
was	NULL
decreased	NULL
following	NULL
dex	NULL
treatment	NULL
were	NULL
detected	NULL
only	NULL
in	NULL
GR-wt	NULL
and	NULL
GR-LS7-expressing	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
in	NULL
parental	NULL
GR~	NULL
cells	NULL
.	NULL

Only	NULL
15	NULL
randomly	NULL
chosen	NULL
primer	NULL
combinations	NULL
have	NULL
been	NULL
analyzed	NULL
.	NULL

If	NULL
the	NULL
repressive	NULL
function	NULL
of	NULL
the	NULL
GR	NULL
,	NULL
exemplified	NULL
by	NULL
its	NULL
interference	NULL
with	NULL
AP-1	NULL
activity	NULL
,	NULL
was	NULL
necessary	NULL
and	NULL
sufficient	NULL
to	NULL
induce	NULL
apoptosis	NULL
,	NULL
this	NULL
would	NULL
predict	NULL
that	NULL
the	NULL
same	NULL
result	NULL
should	NULL
be	NULL
obtained	NULL
using	NULL
another	NULL
nuclear	NULL
receptor	NULL
having	NULL
similar	NULL
transcription	NULL
interfering	NULL
capabili-ties	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypothesis	NULL
,	NULL
we	NULL
selected	NULL
the	NULL
RA	NULL
receptor	NULL
,	NULL
RARa	NULL
.	NULL

To	NULL
activate	NULL
transcription	NULL
in	NULL
a	NULL
ligand-dependent	NULL
manner	NULL
,	NULL
RARa	NULL
binds	NULL
to	NULL
specific	NULL
response	NULL
elements	NULL
,	NULL
RAREs	NULL
,	NULL
that	NULL
are	NULL
different	NULL
from	NULL
GREs	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
Glass	NULL
and	NULL
Rosenfeld	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

However	NULL
,	NULL
like	NULL
the	NULL
GR	NULL
,	NULL
RARa	NULL
interferes	NULL
with	NULL
AP-1	NULL
activity	NULL
in	NULL
a	NULL
ligand-dependent	NULL
fashion	NULL
(	NULL
Schiile	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Yang-Yen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

This	NULL
interference	NULL
also	NULL
does	NULL
not	NULL
require	NULL
direct	NULL
binding	NULL
of	NULL
RAR	NULL
to	NULL
DNA	NULL
.	NULL

In	NULL
many	NULL
systems	NULL
,	NULL
RA	NULL
induces	NULL
cellular	NULL
differentiation	NULL
(	NULL
Ragsdale	NULL
and	NULL
Brockes	NULL
,	NULL
1991	NULL
)	NULL
,	NULL
whereas	NULL
in	NULL
a	NULL
few	NULL
instances	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
cell	NULL
death	NULL
(	NULL
Alles	NULL
and	NULL
Sulik	NULL
,	NULL
1990	NULL
;	NULL
Piacentini	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Since	NULL
no	NULL
RAR	NULL
mRNA	NULL
was	NULL
detected	NULL
in	NULL
parental	NULL
Jurkat	NULL
cells	NULL
,	NULL
we	NULL
established	NULL
Jurkat	NULL
cells	NULL
expressing	NULL
stably	NULL
transfected	NULL
RARa	NULL
using	NULL
a	NULL
pRc/	NULL
Bact-RARa	NULL
expression	NULL
vector	NULL
.	NULL

When	NULL
exposed	NULL
to	NULL
10~°	NULL
M	NULL
RA	NULL
,	NULL
cells	NULL
from	NULL
RARo-expressing	NULL
clones	NULL
died	NULL
within	NULL
72	NULL
h	NULL
,	NULL
showing	NULL
the	NULL
typical	NULL
internucleosomal	NULL
DNA	NULL
degradation	NULL
pattern	NULL
,	NULL
whereas	NULL
parental	NULL
Jurkat	NULL
cells	NULL
did	NULL
not	NULL
(	NULL
Figure	NULL
6	NULL
)	NULL
.	NULL

Subsequently	NULL
,	NULL
we	NULL
assayed	NULL
the	NULL
effect	NULL
of	NULL
RA	NULL
on	NULL
c-myc	NULL
expression	NULL
.	NULL

c-myc	NULL
mRNA	NULL
levels	NULL
did	NULL
not	NULL
change	NULL
following	NULL
Glucocorticoid-induced	NULL
apoptosis	NULL
parental	NULL
RAR-G10	NULL
RAR-H10	NULL
ra	NULL
|-	NULL
+	NULL
[	NULL
[	NULL
-	NULL
+	NULL
]	NULL
[	NULL
-	NULL
~	NULL
]	NULL
cwnies	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

DNA	NULL
fragmentation	NULL
associated	NULL
with	NULL
RA-induced	NULL
apoptosis	NULL
.	NULL

Parental	NULL
Jurkat	NULL
cells	NULL
that	NULL
are	NULL
RAR~	NULL
and	NULL
RARa	NULL
transfected	NULL
clones	NULL
G10	NULL
and	NULL
H10	NULL
were	NULL
incubated	NULL
with	NULL
10~°	NULL
M	NULL
RA	NULL
.	NULL

After	NULL
48	NULL
h	NULL
,	NULL
DNA	NULL
was	NULL
extracted	NULL
,	NULL
end-labeled	NULL
with	NULL
[	NULL
0-	NULL
``	NULL
``	NULL
P	NULL
]	NULL
ddATP	NULL
,	NULL
electrophoresed	NULL
through	NULL
a	NULL
2	NULL
%	NULL
agarose	NULL
gel	NULL
and	NULL
autoradiographed	NULL
.	NULL

parental	NULL
RAR-H10	NULL
RAR-G10	NULL
|	NULL
[	NULL
Z	NULL
]	NULL
>	NULL
hsra	NULL
[	NULL
o	NULL
2	NULL
s	NULL
sl	NULL
[	NULL
o	NULL
2	NULL
s	NULL
sl	NULL
[	NULL
o	NULL
2	NULL
s	NULL
8	NULL
myc	NULL
Cuzh	NULL
ands	NULL
~	NULL
»	NULL
Such	NULL
Suis	NULL
Smale	NULL
o-tub	NULL
.	NULL

Cuib	NULL
duais	NULL
duas	NULL
Olle	NULL
wan	NULL
wes	NULL
wor	NULL
With	NULL
Toit	NULL
Twr	NULL
t	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Effects	NULL
of	NULL
RA	NULL
on	NULL
c-myc	NULL
expression	NULL
in	NULL
parental	NULL
and	NULL
RARa-transfected	NULL
Jurkat	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
grown	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10~°	NULL
M	NULL
RA	NULL
for	NULL
the	NULL
indicated	NULL
intervals	NULL
and	NULL
RNA	NULL
was	NULL
extracted	NULL
and	NULL
analyzed	NULL
with	NULL
a	NULL
human	NULL
c-Myc	NULL
probe	NULL
as	NULL
described	NULL
in	NULL
Figure	NULL
4	NULL
.	NULL

RA	NULL
treatment	NULL
of	NULL
the	NULL
parental	NULL
cells	NULL
,	NULL
but	NULL
decreased	NULL
markedly	NULL
in	NULL
RARo-expressing	NULL
cells	NULL
over	NULL
a	NULL
period	NULL
of	NULL
8	NULL
h	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
RA	NULL
sensitivity	NULL
of	NULL
the	NULL
parental	NULL
cells	NULL
suggests	NULL
that	NULL
they	NULL
do	NULL
not	NULL
express	NULL
functional	NULL
RA	NULL
receptor	NULL
.	NULL

Discussion	NULL
Since	NULL
the	NULL
classical	NULL
mode	NULL
of	NULL
action	NULL
of	NULL
the	NULL
ligand-activated	NULL
GR	NULL
is	NULL
induction	NULL
of	NULL
gene	NULL
transcription	NULL
(	NULL
Yamamoto	NULL
and	NULL
Alberts	NULL
,	NULL
1975	NULL
)	NULL
,	NULL
it	NULL
has	NULL
been	NULL
assumed	NULL
for	NULL
many	NULL
years	NULL
that	NULL
T	NULL
cell	NULL
apoptosis	NULL
is	NULL
mediated	NULL
by	NULL
induction	NULL
of	NULL
'lysis	NULL
genes	NULL
'	NULL
(	NULL
Gasson	NULL
and	NULL
Bourgeois	NULL
,	NULL
1983	NULL
)	NULL
.	NULL

However	NULL
,	NULL
despite	NULL
the	NULL
isolation	NULL
of	NULL
two	NULL
cDNAs	NULL
for	NULL
mRNAs	NULL
whose	NULL
expression	NULL
correlates	NULL
with	NULL
induction	NULL
of	NULL
apoptosis	NULL
(	NULL
Owens	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
no	NULL
functional	NULL
glucocorticoid-inducible	NULL
'lysis	NULL
genes	NULL
'	NULL
were	NULL
identified	NULL
.	NULL

The	NULL
work	NULL
described	NULL
above	NULL
casts	NULL
serious	NULL
doubts	NULL
on	NULL
the	NULL
'lysis-gene	NULL
'	NULL
hypothesis	NULL
and	NULL
strongly	NULL
suggests	NULL
that	NULL
an	NULL
alternative	NULL
mechanism	NULL
is	NULL
at	NULL
par	NULL
.	NULL

As	NULL
we	NULL
show	NULL
,	NULL
a	NULL
variant	NULL
457	NULL
A.Helmberg	NULL
et	NULL
al	NULL
.	NULL

GR	NULL
that	NULL
is	NULL
severely	NULL
compromised	NULL
in	NULL
its	NULL
ability	NULL
to	NULL
activate	NULL
GRE-mediated	NULL
gene	NULL
transcription	NULL
(	NULL
Godowski	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
,	NULL
yet	NULL
fully	NULL
capable	NULL
of	NULL
interfering	NULL
with	NULL
AP-1	NULL
activity	NULL
(	NULL
Yang-Yen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
confers	NULL
full	NULL
glucocorticoid	NULL
sensitivity	NULL
when	NULL
expressed	NULL
at	NULL
normal	NULL
levels	NULL
in	NULL
GR-deficient	NULL
Jurkat	NULL
cells	NULL
.	NULL

Analysis	NULL
of	NULL
five	NULL
different	NULL
cell	NULL
clones	NULL
expressing	NULL
this	NULL
mutant	NULL
receptor	NULL
,	NULL
LS7	NULL
,	NULL
indicates	NULL
that	NULL
they	NULL
all	NULL
undergo	NULL
apoptosis	NULL
in	NULL
response	NULL
to	NULL
the	NULL
same	NULL
concentration	NULL
of	NULL
dex	NULL
that	NULL
induces	NULL
lysis	NULL
of	NULL
clones	NULL
expressing	NULL
the	NULL
wt	NULL
GR	NULL
,	NULL
even	NULL
though	NULL
they	NULL
exhibit	NULL
highly	NULL
compromised	NULL
GRE-mediated	NULL
gene	NULL
induction	NULL
,	NULL
amounting	NULL
to	NULL
5-10	NULL
%	NULL
of	NULL
wt	NULL
activity	NULL
.	NULL

Likewise	NULL
,	NULL
expression	NULL
of	NULL
RARa	NULL
,	NULL
which	NULL
shares	NULL
only	NULL
its	NULL
AP-1	NULL
interfering	NULL
effect	NULL
with	NULL
the	NULL
GR	NULL
,	NULL
was	NULL
found	NULL
to	NULL
confer	NULL
RA-mediated	NULL
apoptosis	NULL
on	NULL
these	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
strongly	NULL
suggest	NULL
that	NULL
glucocorticoids	NULL
are	NULL
unlikely	NULL
to	NULL
cause	NULL
apoptosis	NULL
,	NULL
at	NULL
least	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
by	NULL
direct	NULL
induction	NULL
of	NULL
'lysis	NULL
genes	NULL
'	NULL
.	NULL

A	NULL
more	NULL
plausible	NULL
hypothesis	NULL
consistent	NULL
with	NULL
our	NULL
findings	NULL
is	NULL
that	NULL
glucocorticoids	NULL
induce	NULL
apoptosis	NULL
by	NULL
inhibiting	NULL
the	NULL
expression	NULL
of	NULL
yet-to-be	NULL
identified	NULL
'survival	NULL
genes	NULL
'	NULL
(	NULL
Raff	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

Previous	NULL
mapping	NULL
of	NULL
GR	NULL
domains	NULL
required	NULL
for	NULL
lysis	NULL
of	NULL
the	NULL
human	NULL
lymphoblastic	NULL
leukemia	NULL
CEM-ICR	NULL
27	NULL
cell	NULL
line	NULL
suggested	NULL
that	NULL
only	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
was	NULL
sufficient	NULL
and	NULL
that	NULL
none	NULL
of	NULL
the	NULL
transcriptional	NULL
activation	NULL
domains	NULL
was	NULL
required	NULL
(	NULL
Nazareth	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

These	NULL
results	NULL
,	NULL
however	NULL
,	NULL
are	NULL
based	NULL
on	NULL
transient	NULL
transfection	NULL
of	NULL
GR	NULL
expression	NULL
vectors	NULL
and	NULL
only	NULL
a	NULL
fraction	NULL
of	NULL
the	NULL
cells	NULL
are	NULL
therefore	NULL
susceptible	NULL
to	NULL
lysis	NULL
under	NULL
such	NULL
conditions	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
transient	NULL
transfection	NULL
usually	NULL
results	NULL
in	NULL
vast	NULL
overexpression	NULL
of	NULL
the	NULL
relevant	NULL
protein	NULL
.	NULL

In	NULL
direct	NULL
contrast	NULL
to	NULL
this	NULL
study	NULL
,	NULL
Dieken	NULL
and	NULL
Miesfeld	NULL
(	NULL
1992	NULL
)	NULL
,	NULL
using	NULL
stably	NULL
transfected	NULL
$	NULL
49	NULL
mouse	NULL
lymphoma	NULL
cells	NULL
,	NULL
reported	NULL
that	NULL
the	NULL
N-terminal	NULL
activation	NULL
domain	NULL
of	NULL
the	NULL
GR	NULL
is	NULL
absolutely	NULL
required	NULL
for	NULL
induction	NULL
of	NULL
apoptosis	NULL
.	NULL

We	NULL
find	NULL
the	NULL
mutant	NULL
that	NULL
lacks	NULL
the	NULL
N-terminal	NULL
activation	NULL
domain	NULL
of	NULL
the	NULL
rat	NULL
GR	NULL
is	NULL
,	NULL
as	NULL
expected	NULL
,	NULL
partially	NULL
compromised	NULL
in	NULL
its	NULL
ability	NULL
to	NULL
activate	NULL
a	NULL
GRE-dependent	NULL
reporter	NULL
gene	NULL
,	NULL
but	NULL
has	NULL
nearly	NULL
normal	NULL
AP-1	NULL
interfering	NULL
activity	NULL
.	NULL

When	NULL
stably	NULL
expressed	NULL
in	NULL
Jurkat	NULL
cells	NULL
this	NULL
construct	NULL
confers	NULL
glucocorticoid	NULL
inducible	NULL
apoptosis	NULL
as	NULL
efficiently	NULL
as	NULL
the	NULL
wt	NULL
GR	NULL
.	NULL

This	NULL
discrepancy	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
use	NULL
of	NULL
a	NULL
slightly	NULL
larger	NULL
N-terminal	NULL
deletion	NULL
by	NULL
Dieken	NULL
and	NULL
Miesfeld	NULL
(	NULL
1992	NULL
)	NULL
,	NULL
which	NULL
may	NULL
have	NULL
attenuated	NULL
the	NULL
transcriptional	NULL
interfering	NULL
activity	NULL
of	NULL
the	NULL
receptor	NULL
in	NULL
addition	NULL
to	NULL
its	NULL
activation	NULL
ability	NULL
.	NULL

Some	NULL
contribution	NULL
of	NULL
N-terminal	NULL
sequences	NULL
to	NULL
transcriptional	NULL
interference	NULL
was	NULL
previously	NULL
reported	NULL
(	NULL
Jonat	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Yeng-Yen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Repression	NULL
of	NULL
potential	NULL
'survival	NULL
genes	NULL
'	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
mediated	NULL
through	NULL
transcriptional	NULL
interference	NULL
between	NULL
the	NULL
activated	NULL
GR	NULL
and	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
AP-1	NULL
.	NULL

As	NULL
we	NULL
show	NULL
here	NULL
and	NULL
previously	NULL
(	NULL
Yang-	NULL
Yen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
the	NULL
LS7	NULL
mutant	NULL
is	NULL
fully	NULL
capable	NULL
of	NULL
interfering	NULL
with	NULL
AP-1	NULL
activity	NULL
.	NULL

Furthermore	NULL
,	NULL
induction	NULL
of	NULL
IL-2	NULL
,	NULL
an	NULL
AP-1	NULL
target	NULL
gene	NULL
(	NULL
Serfling	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Jain	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Ullman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Su	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
,	NULL
is	NULL
fully	NULL
susceptible	NULL
to	NULL
repression	NULL
by	NULL
dex	NULL
in	NULL
LS7-expressing	NULL
clones	NULL
.	NULL

c-myc	NULL
expression	NULL
,	NULL
which	NULL
as	NULL
we	NULL
show	NULL
is	NULL
repressed	NULL
by	NULL
liganded	NULL
GR-wt	NULL
,	NULL
GR-LS7	NULL
and	NULL
RARa	NULL
,	NULL
was	NULL
suggested	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
AP-1	NULL
(	NULL
Hay	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

So	NULL
far	NULL
,	NULL
our	NULL
attempts	NULL
to	NULL
prove	NULL
that	NULL
AP-1	NULL
is	NULL
the	NULL
relevant	NULL
target	NULL
with	NULL
whose	NULL
function	NULL
the	NULL
activated	NULL
GR	NULL
interferes	NULL
to	NULL
induce	NULL
T	NULL
cell	NULL
lysis	NULL
have	NULL
failed	NULL
,	NULL
due	NULL
to	NULL
the	NULL
toxic	NULL
effect	NULL
of	NULL
c-Jun	NULL
or	NULL
c-Fos	NULL
overexpression	NULL
on	NULL
lymphoid	NULL
cells	NULL
(	NULL
A.Helmberg	NULL
and	NULL
N.Auphan	NULL
,	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

458	NULL
Thus	NULL
,	NULL
it	NULL
has	NULL
not	NULL
been	NULL
possible	NULL
to	NULL
obtain	NULL
glucocorticoid-resistant	NULL
clones	NULL
by	NULL
overexpression	NULL
of	NULL
AP-1	NULL
constituents	NULL
.	NULL

Although	NULL
AP-1	NULL
is	NULL
a	NULL
reasonable	NULL
candidate	NULL
for	NULL
regulating	NULL
expression	NULL
of	NULL
'survival	NULL
genes	NULL
'	NULL
,	NULL
the	NULL
activated	NULL
GR	NULL
can	NULL
also	NULL
interfere	NULL
with	NULL
the	NULL
activity	NULL
of	NULL
other	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
octamer	NULL
binding	NULL
proteins	NULL
(	NULL
Weiland	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Although	NULL
IL-2-dependent	NULL
cells	NULL
undergo	NULL
apoptosis	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
withdrawal	NULL
,	NULL
we	NULL
do	NULL
not	NULL
think	NULL
that	NULL
glucocorticoid-induced	NULL
apoptosis	NULL
can	NULL
be	NULL
reduced	NULL
to	NULL
IL-2	NULL
with-drawal	NULL
.	NULL

Our	NULL
Jurkat	NULL
lines	NULL
are	NULL
not	NULL
IL-2	NULL
dependent	NULL
and	NULL
do	NULL
not	NULL
transcribe	NULL
the	NULL
IL-2	NULL
gene	NULL
unless	NULL
activated	NULL
(	NULL
Figure	NULL
4A	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
recombinant	NULL
IL-2	NULL
did	NULL
not	NULL
protect	NULL
the	NULL
cells	NULL
from	NULL
glucocorticoid-induced	NULL
apoptosis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Could	NULL
c-myc	NULL
be	NULL
a	NULL
survival	NULL
gene	NULL
?	NULL

Recently	NULL
,	NULL
Thulasi	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
reported	NULL
that	NULL
repression	NULL
of	NULL
c-myc	NULL
correlated	NULL
with	NULL
induction	NULL
of	NULL
apoptosis	NULL
by	NULL
glucocorticoids	NULL
in	NULL
a	NULL
human	NULL
leukemic	NULL
cell	NULL
line	NULL
and	NULL
that	NULL
transient	NULL
transfection	NULL
with	NULL
c-myc	NULL
expression	NULL
vectors	NULL
provided	NULL
some	NULL
protection	NULL
against	NULL
the	NULL
lethal	NULL
effects	NULL
of	NULL
glucocorticoids	NULL
.	NULL

In	NULL
our	NULL
system	NULL
,	NULL
inhibition	NULL
of	NULL
c-myc	NULL
expression	NULL
preceded	NULL
induction	NULL
of	NULL
apoptosis	NULL
following	NULL
activation	NULL
of	NULL
either	NULL
GR-wt	NULL
,	NULL
GR-LS7	NULL
or	NULL
RARa	NULL
.	NULL

In	NULL
an	NULL
attempt	NULL
to	NULL
protect	NULL
the	NULL
cells	NULL
from	NULL
glucocorticoid-induced	NULL
apoptosis	NULL
,	NULL
we	NULL
generated	NULL
subclones	NULL
of	NULL
GR-wt-expressing	NULL
cells	NULL
that	NULL
constitutively	NULL
overexpressed	NULL
c-myc	NULL
mRNA	NULL
after	NULL
stable	NULL
transfection	NULL
with	NULL
a	NULL
c-Myc	NULL
expression	NULL
vector	NULL
.	NULL

In	NULL
response	NULL
to	NULL
dex	NULL
,	NULL
these	NULL
clones	NULL
still	NULL
underwent	NULL
apoptosis	NULL
.	NULL

However	NULL
,	NULL
immunoblot	NULL
analysis	NULL
of	NULL
the	NULL
c-myc-overexpressing	NULL
cells	NULL
indicated	NULL
that	NULL
dex	NULL
still	NULL
downregulated	NULL
c-myc	NULL
expression	NULL
,	NULL
suggesting	NULL
an	NULL
additional	NULL
level	NULL
of	NULL
interference	NULL
with	NULL
c-myc	NULL
expression	NULL
(	NULL
A.Helmberg	NULL
,	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
can	NULL
neither	NULL
confirm	NULL
nor	NULL
exclude	NULL
the	NULL
requirement	NULL
for	NULL
repression	NULL
of	NULL
c-myc	NULL
expression	NULL
in	NULL
glucocorticoid-induced	NULL
apoptosis	NULL
.	NULL

c-mye	NULL
downregulation	NULL
in	NULL
response	NULL
to	NULL
glucocorticoids	NULL
or	NULL
RA	NULL
is	NULL
not	NULL
T-cell	NULL
specific	NULL
,	NULL
since	NULL
glucocorticoids	NULL
reduce	NULL
c-mye	NULL
mRNA	NULL
levels	NULL
in	NULL
C127	NULL
mouse	NULL
fibroblasts	NULL
(	NULL
O	NULL
'	NULL
Benion	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
and	NULL
RA	NULL
reduces	NULL
c-myc	NULL
mRNA-levels	NULL
in	NULL
HL-60	NULL
promyelocytic	NULL
cells	NULL
(	NULL
Kizaki	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
without	NULL
inducing	NULL
apoptosis	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
expression	NULL
of	NULL
c-myc	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
mitogenic	NULL
signal	NULL
was	NULL
shown	NULL
to	NULL
induce	NULL
the	NULL
apoptosis	NULL
of	NULL
rat-l	NULL
fibroblasts	NULL
(	NULL
Evan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

While	NULL
the	NULL
'survival	NULL
genes	NULL
'	NULL
whose	NULL
expression	NULL
is	NULL
inhibited	NULL
by	NULL
the	NULL
activated	NULL
GR	NULL
remain	NULL
to	NULL
be	NULL
identified	NULL
,	NULL
our	NULL
work	NULL
strongly	NULL
suggests	NULL
that	NULL
interference	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
such	NULL
genes	NULL
is	NULL
sufficient	NULL
for	NULL
induction	NULL
of	NULL
apoptosis	NULL
.	NULL

We	NULL
suggest	NULL
that	NULL
the	NULL
function	NULL
of	NULL
such	NULL
'survival	NULL
genes	NULL
'	NULL
is	NULL
cell	NULL
cycle	NULL
progression	NULL
.	NULL

Glucocorticoids	NULL
are	NULL
known	NULL
to	NULL
lead	NULL
to	NULL
G|	NULL
cell	NULL
cycle	NULL
arrest	NULL
in	NULL
human	NULL
leukemic	NULL
T-cells	NULL
(	NULL
Harmon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1979	NULL
)	NULL
and	NULL
many	NULL
other	NULL
cell	NULL
types	NULL
(	NULL
Goya	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Sanchez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

AP-1	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
required	NULL
for	NULL
cell	NULL
cycle	NULL
progression	NULL
(	NULL
Kovary	NULL
and	NULL
Bravo	NULL
,	NULL
1991	NULL
)	NULL
,	NULL
and	NULL
c-myc	NULL
expression	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
necessary	NULL
for	NULL
S	NULL
to	NULL
G	NULL
,	NULL
/M	NULL
transition	NULL
in	NULL
the	NULL
lymphoid	NULL
BAF-BO3	NULL
cell	NULL
line	NULL
(	NULL
Shibuya	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Likely	NULL
,	NULL
the	NULL
derangement	NULL
of	NULL
these	NULL
parameters	NULL
caused	NULL
by	NULL
glucocorticoid	NULL
action	NULL
can	NULL
not	NULL
be	NULL
made	NULL
up	NULL
for	NULL
by	NULL
constitutive	NULL
overexpression	NULL
of	NULL
a	NULL
single	NULL
proto-oncogene	NULL
.	NULL

Yet	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
by	NULL
interfering	NULL
with	NULL
normal	NULL
cell	NULL
cycle	NULL
progression	NULL
,	NULL
glucocorticoids	NULL
or	NULL
any	NULL
other	NULL
agent	NULL
having	NULL
the	NULL
same	NULL
effect	NULL
,	NULL
such	NULL
as	NULL
RA	NULL
,	NULL
may	NULL
trigger	NULL
a	NULL
default	NULL
pathway	NULL
resulting	NULL
in	NULL
activation	NULL
of	NULL
the	NULL
constitutively	NULL
expressed	NULL
,	NULL
but	NULL
inactive	NULL
,	NULL
nuclease	NULL
that	NULL
causes	NULL
the	NULL
internucleosomal	NULL
cleavage	NULL
of	NULL
chromatin	NULL
.	NULL

Other	NULL
processes	NULL
involved	NULL
in	NULL
programmed	NULL
cell	NULL
death	NULL
are	NULL
likely	NULL
to	NULL
be	NULL
activated	NULL
through	NULL
the	NULL
same	NULL
pathway	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Cell	NULL
culture	NULL
Normal	NULL
Jurkat	NULL
cells	NULL
and	NULL
TAg	NULL
Jurkat	NULL
cells	NULL
(	NULL
Clipstone	NULL
and	NULL
Crabtree	NULL
,	NULL
1992	NULL
)	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
10	NULL
mM	NULL
HEPES	NULL
and	NULL
50	NULL
uM	NULL
B-mercaptoethanol	NULL
.	NULL

Plasmids	NULL
The	NULL
expression	NULL
vector	NULL
for	NULL
stable	NULL
transfection	NULL
,	NULL
pRe/Bact	NULL
,	NULL
was	NULL
constructed	NULL
by	NULL
exchanging	NULL
the	NULL
Nrul-	NULL
HindIII	NULL
fragment	NULL
containing	NULL
the	NULL
CMV	NULL
promoter	NULL
of	NULL
pRe/CMV	NULL
(	NULL
InVitrogen	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
with	NULL
the	NULL
1.3	NULL
kb	NULL
HindIII	NULL
fragment	NULL
of	NULL
pAGS	NULL
(	NULL
Miyazaka	NULL
er	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

The	NULL
Xbal	NULL
fragments	NULL
containing	NULL
the	NULL
full	NULL
length	NULL
coding	NULL
sequences	NULL
of	NULL
either	NULL
GR-wt	NULL
or	NULL
GR-LS7	NULL
were	NULL
subcloned	NULL
from	NULL
p6R	NULL
(	NULL
Godowski	NULL
er	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
into	NULL
pRe/CMV	NULL
,	NULL
followed	NULL
by	NULL
ligating	NULL
the	NULL
large	NULL
Pvul-Notl	NULL
fragment	NULL
of	NULL
the	NULL
resultant	NULL
plasmids	NULL
,	NULL
containing	NULL
the	NULL
cDNA	NULL
,	NULL
to	NULL
the	NULL
small	NULL
Pvul-Notl	NULL
fragment	NULL
of	NULL
pRe/Bact	NULL
,	NULL
containing	NULL
the	NULL
B	NULL
actin	NULL
promoter	NULL
,	NULL
to	NULL
generate	NULL
the	NULL
expression	NULL
vectors	NULL
pRe/Bact-GR-wt	NULL
and	NULL
pRe/Bact-GR-LS7	NULL
.	NULL

pRe/Bact-GR-NDel	NULL
was	NULL
derived	NULL
from	NULL
pRC/Bact-GR-wt	NULL
by	NULL
deletion	NULL
of	NULL
the	NULL
1050	NULL
bp	NULL
HindIII	NULL
fragment	NULL
containing	NULL
the	NULL
324	NULL
N-terminal	NULL
codons	NULL
.	NULL

This	NULL
eliminates	NULL
the	NULL
N-terminal	NULL
activation	NULL
domain	NULL
located	NULL
at	NULL
codons	NULL
77-262	NULL
(	NULL
Hollenberg	NULL
and	NULL
Evans	NULL
,	NULL
1988	NULL
)	NULL
.	NULL

Translation	NULL
of	NULL
this	NULL
mutant	NULL
probably	NULL
starts	NULL
at	NULL
Met336	NULL
.	NULL

pRe/	NULL
Bact-RARa	NULL
was	NULL
constructed	NULL
by	NULL
subcloning	NULL
the	NULL
cDNA	NULL
encoding	NULL
human	NULL
RARa	NULL
(	NULL
Glass	NULL
ert	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
into	NULL
the	NULL
HindIII	NULL
and	NULL
Nof	NULL
!	NULL

sites	NULL
of	NULL
pRe/Bact	NULL
.	NULL

The	NULL
reporter	NULL
plasmids	NULL
used	NULL
were	NULL
a	NULL
MMTV-LUC	NULL
reporter	NULL
containing	NULL
two	NULL
consensus	NULL
GREs	NULL
(	NULL
Drouin	NULL
ert	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
and	NULL
the	NULL
AP-1-dependent	NULL
-73Col-LUC	NULL
(	NULL
Deng	NULL
and	NULL
Karin	NULL
,	NULL
1993	NULL
)	NULL
derived	NULL
from	NULL
the	NULL
human	NULL
collagenase	NULL
promoter	NULL
(	NULL
Angel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
.	NULL

Isolation	NULL
of	NULL
stable	NULL
transfectants	NULL
10	NULL
``	NULL
Jurkat	NULL
cells	NULL
in	NULL
0.5	NULL
ml	NULL
of	NULL
fresh	NULL
medium	NULL
were	NULL
electroporated	NULL
at	NULL
960	NULL
uFD	NULL
,	NULL
280	NULL
V	NULL
with	NULL
20	NULL
ug	NULL
of	NULL
Pvul-linearized	NULL
pRe/Bact-GR-wt	NULL
,	NULL
pRe/	NULL
Bact-GR-LS7	NULL
,	NULL
pRe/Bact-NDel	NULL
or	NULL
pRe/Bact-RARa	NULL
,	NULL
respectively	NULL
.	NULL

Subsequently	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
aliquotted	NULL
into	NULL
96-well	NULL
plates	NULL
and	NULL
,	NULL
beginning	NULL
with	NULL
the	NULL
next	NULL
day	NULL
,	NULL
kept	NULL
at	NULL
1.5	NULL
mg/ml	NULL
G418	NULL
(	NULL
60	NULL
%	NULL
active	NULL
compound	NULL
)	NULL
.	NULL

G418-resistant	NULL
clones	NULL
developed	NULL
that	NULL
were	NULL
replicated	NULL
and	NULL
examined	NULL
by	NULL
thymidine	NULL
incorporation	NULL
assays	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
10~°	NULL
M	NULL
dex	NULL
or	NULL
RA	NULL
.	NULL

Some	NULL
of	NULL
the	NULL
clones	NULL
demonstrating	NULL
glucocorticoid-dependent	NULL
inhibition	NULL
of	NULL
thymidine	NULL
incorporation	NULL
were	NULL
recloned	NULL
by	NULL
limiting	NULL
dilution	NULL
.	NULL

Northern	NULL
analysis	NULL
of	NULL
the	NULL
resulting	NULL
clones	NULL
revealed	NULL
high	NULL
expression	NULL
levels	NULL
of	NULL
the	NULL
transfected	NULL
GR	NULL
or	NULL
RARa	NULL
that	NULL
were	NULL
not	NULL
influenced	NULL
by	NULL
cell	NULL
treatment	NULL
with	NULL
TPA/ionomycin	NULL
or	NULL
dex	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

No	NULL
endogenous	NULL
GR	NULL
or	NULL
RARa	NULL
message	NULL
was	NULL
detected	NULL
.	NULL

Transient	NULL
transfections	NULL
Logarithmically	NULL
growing	NULL
cells	NULL
were	NULL
centrifuged	NULL
,	NULL
resuspended	NULL
in	NULL
fresh	NULL
medium	NULL
at	NULL
10	NULL
``	NULL
/0.5	NULL
ml	NULL
,	NULL
electroporated	NULL
at	NULL
960	NULL
uF	NULL
,	NULL
320	NULL
V	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
reporter	NULL
plasmid	NULL
and	NULL
,	NULL
in	NULL
the	NULL
cases	NULL
of	NULL
TAg	NULL
Jurkat	NULL
cells	NULL
,	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
expression	NULL
vector	NULL
.	NULL

Electroporated	NULL
cells	NULL
were	NULL
then	NULL
diluted	NULL
to	NULL
10	NULL
ml	NULL
with	NULL
fresh	NULL
medium	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
normalized	NULL
to	NULL
the	NULL
protein	NULL
concentration	NULL
of	NULL
extracts	NULL
.	NULL

Thymidine	NULL
incorporation	NULL
assays	NULL
Approximately	NULL
1.25	NULL
%	NULL
10°	NULL
cells/ml	NULL
were	NULL
seeded	NULL
in	NULL
microtiter	NULL
plates	NULL
and	NULL
grown	NULL
for	NULL
42	NULL
h	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
dex	NULL
,	NULL
followed	NULL
by	NULL
addition	NULL
of	NULL
methyl-	NULL
[	NULL
3H1thymidine	NULL
(	NULL
Amersham	NULL
,	NULL
5	NULL
Ci/mmol	NULL
!	NULL
)	NULL

to	NULL
a	NULL
final	NULL
activity	NULL
of	NULL
4	NULL
pCi/ml	NULL
for	NULL
an	NULL
additional	NULL
8	NULL
h.	NULL
Subsequently	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
counted	NULL
.	NULL

DNA	NULL
fragmentation	NULL
assay	NULL
After	NULL
having	NULL
been	NULL
grown	NULL
for	NULL
24	NULL
or	NULL
48	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
appropriate	NULL
hormone	NULL
,	NULL
~2X	NULL
10°	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
400	NULL
ul	NULL
of	NULL
DNA	NULL
isolation	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
pH	NULL
8.0	NULL
,	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
25	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
%	NULL
SDS	NULL
and	NULL
0.5	NULL
mg/ml	NULL
proteinase	NULL
K	NULL
)	NULL
.	NULL

After	NULL
overnight	NULL
incubation	NULL
at	NULL
37°C	NULL
,	NULL
DNA	NULL
was	NULL
ethanol	NULL
precipitated	NULL
,	NULL
resuspended	NULL
in	NULL
400	NULL
pil	NULL
of	NULL
TE	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
containing	NULL
10	NULL
mg/ml	NULL
RNase	NULL
A	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
2	NULL
h.	NULL
Samples	NULL
were	NULL
extracted	NULL
with	NULL
phenol/chloroform	NULL
followed	NULL
by	NULL
chloroform	NULL
,	NULL
and	NULL
ethanol	NULL
precipitated	NULL
.	NULL

DNA	NULL
was	NULL
resuspended	NULL
in	NULL
TE	NULL
buffer	NULL
and	NULL
quantified	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
DNA	NULL
were	NULL
either	NULL
directly	NULL
resolved	NULL
on	NULL
a	NULL
2	NULL
%	NULL
agarose	NULL
gel	NULL
and	NULL
visualized	NULL
by	NULL
ethidium	NULL
bromide	NULL
or	NULL
first	NULL
end-labeled	NULL
using	NULL
terminal	NULL
transferase	NULL
and	NULL
[	NULL
&	NULL
-P	NULL
]	NULL
ddATP	NULL
as	NULL
described	NULL
(	NULL
Tilly	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

In	NULL
the	NULL
Glucocorticoid-induced	NULL
apoptosis	NULL
latter	NULL
case	NULL
,	NULL
the	NULL
gel	NULL
was	NULL
dried	NULL
under	NULL
vacuum	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
autoradiographed	NULL
.	NULL

Differential	NULL
mRNA	NULL
display	NULL
This	NULL
was	NULL
done	NULL
using	NULL
total	NULL
cellular	NULL
RNA	NULL
exactly	NULL
as	NULL
described	NULL
by	NULL
Liang	NULL
and	NULL
Pardee	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

Acknowledgements	NULL
We	NULL
thank	NULL
Drs	NULL
PJ.Godowski	NULL
and	NULL
K.R.Yamamoto	NULL
for	NULL
the	NULL
plasmids	NULL
encoding	NULL
the	NULL
wt	NULL
rat	NULL
GR	NULL
and	NULL
the	NULL
LS7	NULL
mutant	NULL
,	NULL
Dr	NULL
C.Glass	NULL
for	NULL
the	NULL
human	NULL
RARa	NULL
and	NULL
Dr	NULL
W.H.Lamers	NULL
for	NULL
the	NULL
human	NULL
glutamine	NULL
synthase	NULL
cDNA	NULL
.	NULL

We	NULL
further	NULL
thank	NULL
Dr	NULL
M.Haas	NULL
for	NULL
his	NULL
support	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grant	NULL
PO1-CA	NULL
50528	NULL
from	NULL
the	NULL
NCI	NULL
.	NULL

A.H.	NULL
was	NULL
supported	NULL
by	NULL
Erwin	NULL
Schrodinger	NULL
fellowships	NULL
(	NULL
JO753	NULL
and	NULL
JO925	NULL
)	NULL
from	NULL
the	NULL
Austrian	NULL
Science	NULL
Foundation	NULL
,	NULL
N.A	NULL
.	NULL

by	NULL
fellowships	NULL
fom	NULL
the	NULL
Association	NULL
pour	NULL
la	NULL
Recherche	NULL
contre	NULL
le	NULL
Cancer	NULL
and	NULL
from	NULL
INSERM	NULL
and	NULL
C.C	NULL
.	NULL

by	NULL
a	NULL
fellowship	NULL
from	NULL
the	NULL
Fundacion	NULL
Ramon	NULL
Areces	NULL
(	NULL
Spain	NULL
)	NULL
.	NULL

References	NULL
Alles	NULL
,	NULL
A.J	NULL
.	NULL

and	NULL
Sulik	NULL
,	NULL
K.K	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Development	NULL
,	NULL
108	NULL
,	NULL
73-81	NULL
.	NULL

Angel	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Karin	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
,	NULL
1072	NULL
,	NULL
129-157	NULL
.	NULL

AngeL	NULL
,	NULL
P	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Cell	NULL
,	NULL
49	NULL
,	NULL
729-739	NULL
.	NULL

Arya	NULL
,	NULL
S.K	NULL
.	NULL

,	NULL
Wong-Staal	NULL
,	NULL
F	NULL
.	NULL

and	NULL
Gallo	NULL
,	NULL
R.C	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
133	NULL
,	NULL
273-276	NULL
.	NULL

Baxter	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
Harris	NULL
,	NULL
A.W	NULL
.	NULL

,	NULL
Tomkins	NULL
,	NULL
G.M	NULL
.	NULL

and	NULL
Cohn	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1971	NULL
)	NULL
Science	NULL
,	NULL
171	NULL
,	NULL
189-191	NULL
.	NULL

Bazar	NULL
,	NULL
L.S	NULL
.	NULL

and	NULL
Deeg	NULL
,	NULL
H.J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Exp	NULL
.	NULL

Hematol	NULL
.	NULL

,	NULL
20	NULL
,	NULL
80-86	NULL
.	NULL

Bourgeois	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Newby	NULL
,	NULL
R.F	NULL
.	NULL

(	NULL
1977	NULL
)	NULL
Cell	NULL
,	NULL
11	NULL
,	NULL
423-430	NULL
.	NULL

Cantrell	NULL
,	NULL
D.A	NULL
.	NULL

and	NULL
Smith	NULL
,	NULL
K.A	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Science	NULL
,	NULL
224	NULL
,	NULL
1312-1316	NULL
.	NULL

Caron-Leslie	NULL
,	NULL
L.A.	NULL
,	NULL
Schwartzman	NULL
,	NULL
R.A.	NULL
,	NULL
Gaido	NULL
,	NULL
M.L	NULL
.	NULL

,	NULL
Compton.M.M	NULL
.	NULL

and	NULL
Cidlowski	NULL
,	NULL
J.A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Steroid	NULL
Biochem	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
40	NULL
,	NULL
661-671	NULL
.	NULL

Clipstone	NULL
,	NULL
N.A	NULL
.	NULL

and	NULL
Crabtree	NULL
,	NULL
G.R	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nature	NULL
,	NULL
357	NULL
,	NULL
695-697	NULL
.	NULL

Cohen	NULL
,	NULL
J.J	NULL
.	NULL

and	NULL
Duke	NULL
,	NULL
R.C	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
J	NULL
.	NULL

/mmunol	NULL
.	NULL

,	NULL
132	NULL
,	NULL
38-42	NULL
.	NULL

Cohen	NULL
,	NULL
J.J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
In	NULL
Schleimer	NULL
,	NULL
R.P	NULL
.	NULL

,	NULL
Claman	NULL
,	NULL
H.N	NULL
.	NULL

and	NULL
Oronsky	NULL
,	NULL
A	NULL
.	NULL

(	NULL
eds	NULL
)	NULL
,	NULL
Anti-inflammatory	NULL
Steroid	NULL
action	NULL
:	NULL
Basic	NULL
and	NULL
Clinical	NULL
Aspects	NULL
.	NULL

Academic	NULL
Press	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
,	NULL
pp	NULL
.	NULL

110-131	NULL
.	NULL

Cupps	NULL
,	NULL
TR	NULL
.	NULL

and	NULL
Fauci	NULL
,	NULL
A.S	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
Immunol	NULL
.	NULL

Rev	NULL
.	NULL

,	NULL
65	NULL
,	NULL
133-155	NULL
.	NULL

Deng	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Karin	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Genes	NULL
Devel	NULL
.	NULL

,	NULL
7	NULL
,	NULL
479-490	NULL
.	NULL

Dieken	NULL
,	NULL
E.S	NULL
$	NULL
.	NULL

and	NULL
Miesfeld	NULL
,	NULL
R.L	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
12	NULL
,	NULL
589-597	NULL
.	NULL

Dowd	NULL
,	NULL
D.R	NULL
.	NULL

and	NULL
Miesfeld	NULL
,	NULL
R.L	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
12	NULL
,	NULL
3600-3608	NULL
.	NULL

Drouin	NULL
,	NULL
J.	NULL
,	NULL
Sun	NULL
,	NULL
Chamberland	NULL
,	NULL
M.	NULL
,	NULL
Gauthier	NULL
,	NULL
Y.	NULL
,	NULL
De	NULL
Lean	NULL
,	NULL
A.	NULL
,	NULL
Nemer	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Schmidt	NULL
,	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
12	NULL
,	NULL
145-156	NULL
.	NULL

Evan	NULL
,	NULL
G.I	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
,	NULL
69	NULL
,	NULL
119-128	NULL
.	NULL

Galili	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
J.	NULL
Steroid	NULL
Biochem	NULL
.	NULL

,	NULL
19	NULL
,	NULL
483-490	NULL
.	NULL

Gasson	NULL
,	NULL
J.C	NULL
.	NULL

and	NULL
Bourgeois	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

,	NULL
96	NULL
,	NULL
409-415	NULL
.	NULL

Gillis	NULL
,	NULL
S.	NULL
,	NULL
Ferm	NULL
,	NULL
M.M	NULL
.	NULL

,	NULL
Ou	NULL
,	NULL
W	NULL
.	NULL

and	NULL
Smith	NULL
,	NULL
K.A	NULL
.	NULL

(	NULL
1978	NULL
)	NULL
J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
120	NULL
,	NULL
2027-2032	NULL
.	NULL

Gillis	NULL
,	NULL
.S	NULL
.	NULL

,	NULL
Crabtree	NULL
,	NULL
G.R	NULL
.	NULL

and	NULL
Smith.K.A	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
123	NULL
,	NULL
1624-1631	NULL
.	NULL

Glass	NULL
,	NULL
C.K	NULL
.	NULL

and	NULL
Rosenfeld	NULL
,	NULL
M.G	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
In	NULL
Foulkes	NULL
,	NULL
G	NULL
.	NULL

and	NULL
Cohen	NULL
,	NULL
P	NULL
.	NULL

(	NULL
eds	NULL
)	NULL
,	NULL
The	NULL
Hormonal	NULL
Control	NULL
of	NULL
Gene	NULL
Transcription	NULL
.	NULL

Elsevier	NULL
,	NULL
Amsterdam	NULL
,	NULL
Vol	NULL
.	NULL

6	NULL
,	NULL
pp	NULL
.	NULL

299-327	NULL
.	NULL

Glass	NULL
,	NULL
C.K	NULL
.	NULL

,	NULL
Lipkin	NULL
,	NULL
S.M	NULL
.	NULL

,	NULL
Devary,0.V	NULL
.	NULL

and	NULL
Rosenfeld	NULL
,	NULL
M.G	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Cell	NULL
,	NULL
54	NULL
,	NULL
313-323	NULL
.	NULL

Godowski	NULL
,	NULL
PJ	NULL
.	NULL

,	NULL
Sakai	NULL
,	NULL
D.D	NULL
.	NULL

and	NULL
Yamamoto	NULL
,	NULL
K.R	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
In	NULL
Gralla	NULL
,	NULL
J.D	NULL
.	NULL

(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
DNA-Protein	NULL
Interactions	NULL
in	NULL
Transcription	NULL
.	NULL

UCLA	NULL
Symposia	NULL
on	NULL
Molecular	NULL
and	NULL
Cellular	NULL
Biology	NULL
,	NULL
New	NULL
Series	NULL
,	NULL
Alan	NULL
R.Liss	NULL
,	NULL
New	NULL
York	NULL
,	NULL
Vol	NULL
.	NULL

95	NULL
,	NULL
pp	NULL
.	NULL

197-210	NULL
.	NULL

Goya	NULL
,	NULL
L.	NULL
,	NULL
Maiyar	NULL
,	NULL
A.C.	NULL
,	NULL
Ge	NULL
,	NULL
Y.	NULL
,	NULL
Firestone	NULL
,	NULL
G.L	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

,	NULL
7	NULL
,	NULL
1121-1132	NULL
.	NULL

Harbour	NULL
,	NULL
D.V	NULL
.	NULL

,	NULL
Chambon	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Thompson	NULL
,	NULL
E.B	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Steroid	NULL
Biochem	NULL
.	NULL

,	NULL
35	NULL
,	NULL
1-9	NULL
.	NULL

Harmon	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
Norman	NULL
,	NULL
M.R	NULL
.	NULL

,	NULL
Fowlkes	NULL
,	NULL
B.J	NULL
.	NULL

and	NULL
Thompson	NULL
,	NULL
E.B	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

,	NULL
98	NULL
,	NULL
267-278	NULL
.	NULL

Hay	NULL
,	NULL
N.	NULL
,	NULL
Takimoto	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Bishop.J.M	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
3	NULL
,	NULL
293-303	NULL
.	NULL

Haynes.RC..Jr.	NULL
(	NULL
1990	NULL
)	NULL
In	NULL
Gilman	NULL
,	NULL
A.G.	NULL
,	NULL
Roll	NULL
,	NULL
T.W	NULL
.	NULL

,	NULL
Nies	NULL
,	NULL
A.S	NULL
.	NULL

and	NULL
Taylor	NULL
,	NULL
P	NULL
.	NULL

(	NULL
eds	NULL
)	NULL
,	NULL
Goodman	NULL
and	NULL
Gilman	NULL
's	NULL
The	NULL
Pharmacological	NULL
Basis	NULL
of	NULL
Therapeutics	NULL
.	NULL

8th	NULL
edn	NULL
.	NULL

Pergamon	NULL
,	NULL
New	NULL
York	NULL
,	NULL
pp	NULL
.	NULL

1452-1457	NULL
.	NULL

Helmberg	NULL
,	NULL
A.	NULL
,	NULL
Fissler	NULL
,	NULL
R.	NULL
,	NULL
Geley	NULL
,	NULL
S.	NULL
,	NULL
Johrer	NULL
,	NULL
K.	NULL
,	NULL
Kroemer	NULL
,	NULL
G.	NULL
,	NULL
Bick	NULL
,	NULL
G	NULL
.	NULL

and	NULL
Kofler	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
145	NULL
,	NULL
4332-4337	NULL
.	NULL

Hollenberg	NULL
,	NULL
S.M	NULL
.	NULL

,	NULL
and	NULL
Evans	NULL
,	NULL
R.M	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Cell	NULL
,	NULL
55	NULL
,	NULL
899-906	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
Valge-Archer	NULL
,	NULL
V.E	NULL
.	NULL

and	NULL
Rao	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
148	NULL
,	NULL
1240-1250	NULL
.	NULL

459	NULL
A.Helmberg	NULL
et	NULL
al	NULL
.	NULL

Jonat	NULL
,	NULL
C.	NULL
,	NULL
Rahmsdorf	NULL
,	NULL
H.J	NULL
.	NULL

,	NULL
Park	NULL
,	NULL
K.K	NULL
.	NULL

,	NULL
Cato	NULL
,	NULL
A.C.B	NULL
.	NULL

,	NULL
Gebel	NULL
,	NULL
S.	NULL
,	NULL
Ponta	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Herrlich	NULL
,	NULL
P	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
,	NULL
62	NULL
,	NULL
1189-1204	NULL
.	NULL

Kizaki	NULL
,	NULL
M.	NULL
,	NULL
-	NULL
Ikeda	NULL
,	NULL
Y.	NULL
,	NULL
-	NULL
Tanoseki	NULL
,	NULL
R.	NULL
,	NULL
-	NULL
Nakajima	NULL
,	NULL
H.	NULL
,	NULL
-	NULL
Moridawa	NULL
,	NULL
M.	NULL
,	NULL
Sakashita	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Koeffler	NULL
,	NULL
H.P	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Blood	NULL
,	NULL
82	NULL
,	NULL
3592-3599	NULL
.	NULL

Kovary	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Bravo	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
11	NULL
,	NULL
4466-4472	NULL
.	NULL

Liang	NULL
,	NULL
P	NULL
and	NULL
Pardee	NULL
,	NULL
A.B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Science	NULL
,	NULL
257	NULL
,	NULL
967-970	NULL
.	NULL

Martin	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
Lennon	NULL
,	NULL
S.V	NULL
.	NULL

,	NULL
Bonham	NULL
,	NULL
A.M	NULL
.	NULL

and	NULL
Cotter	NULL
,	NULL
T.G	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
145	NULL
,	NULL
1859-1867	NULL
.	NULL

Miyazaki	NULL
,	NULL
J.	NULL
,	NULL
Takaki	NULL
,	NULL
S.	NULL
,	NULL
Araki	NULL
,	NULL
K.	NULL
,	NULL
Tashiro	NULL
,	NULL
F.	NULL
,	NULL
Tominaga	NULL
,	NULL
A.	NULL
,	NULL
Takatsu	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Yamamura	NULL
,	NULL
K	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Gene	NULL
,	NULL
79	NULL
,	NULL
269-277	NULL
.	NULL

Nazareth	NULL
,	NULL
L.V	NULL
.	NULL

,	NULL
Harbour	NULL
,	NULL
D.V	NULL
.	NULL

and	NULL
Thompson	NULL
,	NULL
E.B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
266	NULL
,	NULL
12976-12980	NULL
.	NULL

Norman	NULL
,	NULL
M.R	NULL
.	NULL

and	NULL
Thompson	NULL
,	NULL
E.B	NULL
.	NULL

(	NULL
1977	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

,	NULL
37	NULL
,	NULL
3785-3791	NULL
.	NULL

Northrop	NULL
,	NULL
J.P.	NULL
,	NULL
Crabtree	NULL
,	NULL
G.R	NULL
.	NULL

and	NULL
Mattila	NULL
,	NULL
P.S	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
175	NULL
,	NULL
1235-1245	NULL
.	NULL

O'Banion	NULL
,	NULL
M.K	NULL
.	NULL

,	NULL
Levenson	NULL
,	NULL
R.M	NULL
.	NULL

,	NULL
Brinckmann	NULL
,	NULL
U.G	NULL
.	NULL

and	NULL
Young	NULL
,	NULL
D.A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

,	NULL
6	NULL
,	NULL
1371-1380	NULL
.	NULL

Owens	NULL
,	NULL
G.P	NULL
.	NULL

,	NULL
Hahn	NULL
,	NULL
and	NULL
Cohen	NULL
,	NULL
J.J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
11	NULL
,	NULL
4177-4188	NULL
.	NULL

Parillo	NULL
,	NULL
J.E	NULL
.	NULL

and	NULL
Fauci	NULL
,	NULL
A.S	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Pharmacol	NULL
.	NULL

Toxicol	NULL
.	NULL

,	NULL
19	NULL
,	NULL
179-209	NULL
.	NULL

Piacentini	NULL
,	NULL
M.	NULL
,	NULL
Fesus	NULL
,	NULL
L.	NULL
,	NULL
Farrace	NULL
,	NULL
M.G	NULL
.	NULL

,	NULL
Ghibelli	NULL
,	NULL
L.	NULL
,	NULL
Piredda	NULL
,	NULL
L	NULL
.	NULL

and	NULL
Melino	NULL
,	NULL
G	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Eur	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

,	NULL
54	NULL
,	NULL
246-54	NULL
.	NULL

Pu	NULL
,	NULL
H	NULL
.	NULL

and	NULL
Young	NULL
,	NULL
A.P	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Gene	NULL
,	NULL
81	NULL
,	NULL
169-175	NULL
.	NULL

Raff	NULL
,	NULL
M.C	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nature	NULL
,	NULL
356	NULL
,	NULL
397-400	NULL
.	NULL

Ragsdale	NULL
,	NULL
C.W	NULL
.	NULL

and	NULL
Brockes	NULL
,	NULL
J.P	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
In	NULL
Parker	NULL
,	NULL
M.G	NULL
.	NULL

(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Nuclear	NULL
Hormone	NULL
Receptors	NULL
.	NULL

Academic	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
,	NULL
pp	NULL
.	NULL

235-259	NULL
.	NULL

Sanchez	NULL
,	NULL
L.	NULL
,	NULL
Goya	NULL
,	NULL
L.	NULL
,	NULL
Vallerga	NULL
,	NULL
A.K	NULL
.	NULL

,	NULL
and	NULL
Firestone	NULL
,	NULL
G.L	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

,	NULL
4	NULL
,	NULL
215-225	NULL
.	NULL

Schiile	NULL
,	NULL
R.	NULL
,	NULL
Rangarajan	NULL
,	NULL
P.	NULL
,	NULL
Kliewer	NULL
,	NULL
S.	NULL
,	NULL
Ransone	NULL
,	NULL
L.J	NULL
.	NULL

,	NULL
Yang	NULL
.	NULL

N.	NULL
,	NULL
Verma	NULL
,	NULL
LM	NULL
.	NULL

and	NULL
Evans	NULL
,	NULL
R.M	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
,	NULL
62	NULL
,	NULL
1217-1226	NULL
.	NULL

Schiile	NULL
,	NULL
R.	NULL
,	NULL
Rangarajan	NULL
,	NULL
P.	NULL
,	NULL
Yang	NULL
,	NULL
N.	NULL
,	NULL
Kliewer	NULL
,	NULL
S.	NULL
,	NULL
Ransone	NULL
,	NULL
L.J	NULL
.	NULL

,	NULL
Bolado	NULL
,	NULL
J	NULL
Verma	NULL
,	NULL
LM	NULL
.	NULL

and	NULL
Evans	NULL
,	NULL
R.M	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Nat	NULL
!	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
88	NULL
,	NULL
6092-6097	NULL
.	NULL

Serfling	NULL
,	NULL
E.	NULL
,	NULL
Barthelmiis	NULL
,	NULL
R.	NULL
,	NULL
Pfeuffer	NULL
,	NULL
L.	NULL
,	NULL
Schenk	NULL
,	NULL
B.	NULL
,	NULL
Zarius	NULL
,	NULL
$	NULL
S.	NULL
,	NULL
Swoboda	NULL
,	NULL
R.	NULL
,	NULL
Mercurio	NULL
,	NULL
F	NULL
.	NULL

and	NULL
Karin	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
8	NULL
,	NULL
465-473	NULL
.	NULL

Shi	NULL
,	NULL
Y.	NULL
,	NULL
Glynn	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
GuilbertLJ	NULL
.	NULL

,	NULL
Cotter	NULL
,	NULL
T.G	NULL
.	NULL

,	NULL
Bissonnette.R.P	NULL
.	NULL

and	NULL
Green	NULL
,	NULL
D.R	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Science	NULL
,	NULL
257	NULL
,	NULL
212-214	NULL
.	NULL

Shibuya	NULL
,	NULL
H.	NULL
,	NULL
Yoneyama	NULL
,	NULL
M.	NULL
,	NULL
Ninomiya-Tsuji	NULL
,	NULL
J.	NULL
,	NULL
Matsumoto	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Taniguchi	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
,	NULL
70	NULL
,	NULL
57-67	NULL
.	NULL

Sibley	NULL
,	NULL
C.H	NULL
.	NULL

and	NULL
Tomkins	NULL
,	NULL
G.M	NULL
.	NULL

(	NULL
1974	NULL
)	NULL
Cell	NULL
,	NULL
2	NULL
,	NULL
213-220	NULL
.	NULL

$	NULL
u	NULL
,	NULL
B.	NULL
,	NULL
Jacinto	NULL
,	NULL
E.	NULL
,	NULL
Hibi	NULL
,	NULL
M.	NULL
,	NULL
Kallunki	NULL
,	NULL
T.	NULL
,	NULL
Karin	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Ben-Neriah	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Cell	NULL
,	NULL
77	NULL
,	NULL
727-736	NULL
.	NULL

Thulasi	NULL
,	NULL
R.	NULL
,	NULL
Harbour	NULL
,	NULL
D.V	NULL
.	NULL

and	NULL
Thompson	NULL
,	NULL
E.B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
268	NULL
,	NULL
18306-18312	NULL
.	NULL

Tilly	NULL
,	NULL
J.L	NULL
.	NULL

and	NULL
Hsueh	NULL
,	NULL
A.J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

,	NULL
154	NULL
,	NULL
519-526	NULL
.	NULL

Ucker	NULL
,	NULL
D.S	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Nature	NULL
,	NULL
327	NULL
,	NULL
62-64	NULL
.	NULL

Uliman	NULL
,	NULL
K.S	NULL
.	NULL

,	NULL
Northrop.J.P	NULL
.	NULL

,	NULL
Admon	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Crabtree	NULL
,	NULL
G.R	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
7	NULL
,	NULL
188-196	NULL
.	NULL

Vacca	NULL
,	NULL
A.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
265	NULL
,	NULL
8075-8080	NULL
.	NULL

Van	NULL
den	NULL
Hoff	NULL
,	NULL
Geerts	NULL
W.J.C	NULL
.	NULL

,	NULL
Das	NULL
,	NULL
A.T.	NULL
,	NULL
Moorman	NULL
,	NULL
A.EM	NULL
.	NULL

and	NULL
Lamers	NULL
,	NULL
W.H	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
,	NULL
1090	NULL
,	NULL
249-251	NULL
.	NULL

Weiland	NULL
,	NULL
S.	NULL
,	NULL
Dobbeling	NULL
,	NULL
U	NULL
.	NULL

and	NULL
Rusconi	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
10	NULL
,	NULL
2513-2521	NULL
.	NULL

Weiss	NULL
,	NULL
A.	NULL
and	NULL
Stobo	NULL
,	NULL
J.D	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
160	NULL
,	NULL
1284-1299	NULL
.	NULL

Wyllie	NULL
,	NULL
A.H.	NULL
(	NULL
1980	NULL
)	NULL
Nature	NULL
,	NULL
284	NULL
,	NULL
555-556	NULL
.	NULL

Yamamoto	NULL
,	NULL
K.R	NULL
.	NULL

and	NULL
Alberts	NULL
,	NULL
B.M	NULL
.	NULL

(	NULL
1976	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
45	NULL
,	NULL
722-1746	NULL
.	NULL

Yang-Yen	NULL
,	NULL
HF	NULL
,	NULL
Chambard	NULL
,	NULL
J.C.	NULL
,	NULL
Sun	NULL
,	NULL
YL	NULL
.	NULL

,	NULL
Smeal	NULL
,	NULL
T.	NULL
,	NULL
SchmidtT.J	NULL
.	NULL

,	NULL
Drouin	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Karin	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
,	NULL
62	NULL
,	NULL
1205-1215	NULL
.	NULL

Yang-Yen	NULL
,	NULL
H.F.	NULL
,	NULL
Zhang.X.K	NULL
.	NULL

,	NULL
Graupner	NULL
,	NULL
G.	NULL
,	NULL
Tzukerman	NULL
,	NULL
M.	NULL
,	NULL
Sakamoto	NULL
,	NULL
B.	NULL
,	NULL
Karin	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Pfahl.M	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
New	NULL
Biol	NULL
.	NULL

,	NULL
3	NULL
,	NULL
1206-1219	NULL
.	NULL

Received	NULL
on	NULL
June	NULL
22	NULL
,	NULL
1994	NULL
;	NULL
revised	NULL
on	NULL
November	NULL
3	NULL
,	NULL
1994	NULL
460	NULL

